Regulation	O
of	O
transcription	O
of	O
the	O
human	B-DNA
erythropoietin	I-DNA
receptor	I-DNA
gene	I-DNA
by	O
proteins	O
binding	O
to	O
GATA-1	B-DNA
and	I-DNA
Sp1	I-DNA
motifs	I-DNA
.	O

Erythropoietin	B-protein
(	O
Epo	B-protein
)	O
,	O
the	O
primary	O
regulator	O
of	O
the	O
production	O
of	O
erythroid	B-cell_type
cells	I-cell_type
,	O
acts	O
by	O
binding	O
to	O
a	O
cell	B-protein
surface	I-protein
receptor	I-protein
(	O
EpoR	B-protein
)	O
on	O
erythroid	B-cell_type
progenitors	I-cell_type
.	O

We	O
used	O
deletion	O
analysis	O
and	O
transfection	O
assays	O
with	O
reporter	B-DNA
gene	I-DNA
constructs	I-DNA
to	O
examine	O
the	O
transcription	B-DNA
control	I-DNA
elements	I-DNA
in	O
the	O
5	B-DNA
'	I-DNA
flanking	I-DNA
region	I-DNA
of	O
the	O
human	B-DNA
EpoR	I-DNA
gene	I-DNA
.	O

In	O
erythroid	B-cell_type
cells	I-cell_type
most	O
of	O
the	O
transcription	O
activity	O
was	O
contained	O
in	O
a	O
150	B-DNA
bp	I-DNA
promoter	I-DNA
fragment	O
with	O
binding	B-DNA
sites	I-DNA
for	O
transcription	B-protein
factors	I-protein
AP2	B-protein
,	O
Sp1	B-protein
and	O
the	O
erythroid-specific	B-protein
GATA-1	I-protein
.	O

The	O
150	B-DNA
bp	I-DNA
hEpoR	I-DNA
promoter	I-DNA
exhibited	O
high	O
and	O
low	O
activity	O
in	O
erythroid	O
OCIM1	B-cell_line
and	O
K562	B-cell_line
cells	I-cell_line
,	O
respectively	O
,	O
reflecting	O
the	O
high	O
and	O
low	O
levels	O
of	O
constitutive	O
hEpoR	B-protein
expression	O
.	O

The	O
GATA-1	B-DNA
and	I-DNA
Sp1	I-DNA
binding	I-DNA
sites	I-DNA
in	O
this	O
promoter	O
lacking	O
a	O
TATA	B-DNA
sequence	I-DNA
were	O
necessary	O
for	O
a	O
high	O
level	O
of	O
transcription	O
activation	O
.	O

Protein-DNA	O
binding	O
studies	O
suggested	O
that	O
Sp1	B-protein
and	O
two	O
other	O
CCGCCC	B-protein
binding	I-protein
proteins	I-protein
from	O
erythroid	B-cell_type
and	I-cell_type
non-erythroid	I-cell_type
cells	I-cell_type
could	O
bind	O
to	O
the	O
Sp1	B-DNA
binding	I-DNA
motif	I-DNA
.	O

By	O
increasing	O
GATA-1	B-protein
levels	O
via	O
co-transfection	O
,	O
we	O
were	O
able	O
to	O
transactivate	O
the	O
hEpoR	B-DNA
promoter	I-DNA
in	O
K562	B-cell_line
cells	I-cell_line
and	O
non-erythroid	B-cell_type
cells	I-cell_type
,	O
but	O
not	O
in	O
the	O
highly	O
active	O
OCIM1	B-cell_type
cells	I-cell_type
,	O
although	O
GATA-1	B-RNA
mRNA	I-RNA
levels	O
were	O
comparable	O
in	O
OCIM1	B-cell_line
and	O
K562	B-cell_line
.	O

Interestingly	O
,	O
when	O
we	O
mutated	O
the	O
Sp1	B-DNA
site	I-DNA
,	O
resulting	O
in	O
a	O
marked	O
decrease	O
in	O
hEpoR	B-DNA
promoter	I-DNA
activity	O
,	O
we	O
could	O
restore	O
transactivation	O
by	O
increasing	O
GATA-1	B-protein
levels	O
in	O
OCIM1	B-cell_type
cells	I-cell_type
.	O

These	O
data	O
suggest	O
that	O
while	O
GATA-1	B-protein
can	O
transactivate	O
the	O
EpoR	B-DNA
promoter	I-DNA
,	O
the	O
level	O
of	O
hEpoR	B-DNA
gene	I-DNA
expression	O
does	O
not	O
depend	O
on	O
GATA-1	B-protein
alone	O
.	O

Rather	O
,	O
hEpoR	B-protein
transcription	O
activity	O
depends	O
on	O
coordination	O
between	O
Sp1	B-protein
and	O
GATA-1	B-protein
with	O
other	O
cell-specific	B-protein
factors	I-protein
,	O
including	O
possibly	O
other	O
Sp1-like	B-protein
binding	I-protein
proteins	I-protein
,	O
to	O
provide	O
high	O
level	O
,	O
tissue-specific	O
expression	O
.	O

Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1995	NULL
,	NULL
Vol	NULL
.	NULL

23	NULL
,	NULL
No	NULL
.	NULL

15	NULL
3041-3049	NULL
Regulation	NULL
of	NULL
transcription	NULL
of	NULL
the	NULL
human	NULL
erythropoietin	NULL
receptor	NULL
gene	NULL
by	NULL
proteins	NULL
binding	NULL
to	NULL
GATA-1	NULL
and	NULL
Sp1	NULL
motifs	NULL
Kyung	NULL
Chin	NULL
,	NULL
Naoko	NULL
Oda	NULL
,	NULL
Kun	NULL
Shen	NULL
and	NULL
Constance	NULL
Tom	NULL
Noguchi*	NULL
Laboratory	NULL
of	NULL
Chemical	NULL
Biology	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Diabetes	NULL
,	NULL
Digestive	NULL
and	NULL
Kidney	NULL
Diseases	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892	NULL
,	NULL
USA	NULL
Received	NULL
January	NULL
30	NULL
,	NULL
1995	NULL
;	NULL
Revised	NULL
and	NULL
Accepted	NULL
June	NULL
19	NULL
,	NULL
1995	NULL
ABSTRACT	NULL
Erythropoietin	NULL
(	NULL
Epo	NULL
)	NULL
,	NULL
the	NULL
primary	NULL
regulator	NULL
of	NULL
the	NULL
production	NULL
of	NULL
erythroid	NULL
cells	NULL
,	NULL
acts	NULL
by	NULL
binding	NULL
to	NULL
a	NULL
cell	NULL
surface	NULL
receptor	NULL
(	NULL
EpoR	NULL
)	NULL
on	NULL
erythroid	NULL
progenitors	NULL
.	NULL

We	NULL
used	NULL
deletion	NULL
analysis	NULL
and	NULL
transfection	NULL
assays	NULL
with	NULL
reporter	NULL
gene	NULL
constructs	NULL
to	NULL
examine	NULL
the	NULL
transcription	NULL
control	NULL
elements	NULL
in	NULL
the	NULL
5¢	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
EpoR	NULL
gene	NULL
.	NULL

In	NULL
erythroid	NULL
cells	NULL
most	NULL
of	NULL
the	NULL
transcription	NULL
activity	NULL
was	NULL
contained	NULL
in	NULL
a	NULL
150	NULL
bp	NULL
promoter	NULL
fragment	NULL
with	NULL
binding	NULL
sites	NULL
for	NULL
transcription	NULL
factors	NULL
AP2	NULL
,	NULL
Spi	NULL
and	NULL
the	NULL
erythroid-specific	NULL
GATA-1	NULL
.	NULL

The	NULL
150	NULL
bp	NULL
hEpoR	NULL
promoter	NULL
exhibited	NULL
high	NULL
and	NULL
low	NULL
activity	NULL
in	NULL
erythroid	NULL
OCIM1	NULL
and	NULL
K562	NULL
cells	NULL
,	NULL
respectively	NULL
,	NULL
reflecting	NULL
the	NULL
high	NULL
and	NULL
low	NULL
levels	NULL
of	NULL
constitutive	NULL
hEpoR	NULL
expression	NULL
.	NULL

The	NULL
GATA-1	NULL
and	NULL
Sp1	NULL
binding	NULL
sites	NULL
in	NULL
this	NULL
promoter	NULL
lacking	NULL
a	NULL
TATA	NULL
sequence	NULL
were	NULL
necessary	NULL
for	NULL
a	NULL
high	NULL
level	NULL
of	NULL
transcription	NULL
activation	NULL
.	NULL

Protein-DNA	NULL
binding	NULL
studies	NULL
suggested	NULL
that	NULL
Sp1	NULL
and	NULL
two	NULL
other	NULL
CCGCCC	NULL
binding	NULL
proteins	NULL
from	NULL
erythroid	NULL
and	NULL
non-erythroid	NULL
cells	NULL
could	NULL
bind	NULL
to	NULL
the	NULL
Sp1	NULL
binding	NULL
motif	NULL
.	NULL

By	NULL
increasing	NULL
GATA-1	NULL
levels	NULL
via	NULL
co-transfection	NULL
,	NULL
we	NULL
were	NULL
able	NULL
to	NULL
transactivate	NULL
the	NULL
hEpoR	NULL
promoter	NULL
in	NULL
K562	NULL
cells	NULL
and	NULL
non-erythroid	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
in	NULL
the	NULL
highly	NULL
active	NULL
OCIM1	NULL
cells	NULL
,	NULL
although	NULL
GATA-1	NULL
mRNA	NULL
levels	NULL
were	NULL
comparable	NULL
in	NULL
OCIM1	NULL
and	NULL
K562	NULL
.	NULL

Interestingly	NULL
,	NULL
when	NULL
we	NULL
mutated	NULL
the	NULL
Sp1	NULL
site	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
marked	NULL
decrease	NULL
in	NULL
hEpoR	NULL
promoter	NULL
activity	NULL
,	NULL
we	NULL
could	NULL
restore	NULL
transactivation	NULL
by	NULL
increasing	NULL
GATA-1	NULL
levels	NULL
in	NULL
OCIM1	NULL
cells	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
while	NULL
GATA-1	NULL
can	NULL
transactivate	NULL
the	NULL
EpoR	NULL
promoter	NULL
,	NULL
the	NULL
level	NULL
of	NULL
hEpoR	NULL
gene	NULL
expression	NULL
does	NULL
not	NULL
depend	NULL
on	NULL
GATA-1	NULL
alone	NULL
.	NULL

Rather	NULL
,	NULL
hEpoR	NULL
transcription	NULL
activity	NULL
depends	NULL
on	NULL
coordination	NULL
between	NULL
Sp1	NULL
and	NULL
GATA-1	NULL
with	NULL
other	NULL
cell-specific	NULL
factors	NULL
,	NULL
including	NULL
possibly	NULL
other	NULL
Sp1-like	NULL
binding	NULL
proteins	NULL
,	NULL
to	NULL
provide	NULL
high	NULL
level	NULL
,	NULL
tissue-specific	NULL
expression	NULL
.	NULL

INTRODUCTION	NULL
Erythropoietin	NULL
(	NULL
Epo	NULL
)	NULL
is	NULL
the	NULL
hematopoietic	NULL
cytokine	NULL
responsible	NULL
for	NULL
proliferation	NULL
and	NULL
maturation	NULL
of	NULL
erythroid	NULL
cells	NULL
.	NULL

Epo	NULL
,	NULL
which	NULL
stimulates	NULL
erythroid	NULL
progenitors	NULL
via	NULL
binding	NULL
to	NULL
the	NULL
cell	NULL
surface	NULL
erythropoietin	NULL
receptor	NULL
(	NULL
EpoR	NULL
)	NULL
,	NULL
can	NULL
function	NULL
as	NULL
a	NULL
viability	NULL
factor	NULL
preventing	NULL
apoptosis	NULL
and	NULL
as	NULL
a	NULL
differentiation	NULL
factor	NULL
stimulating	NULL
heme	NULL
production	NULL
and	NULL
globin	NULL
synthesis	NULL
.	NULL

EpoR	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
superfamily	NULL
of	NULL
hematopoietic	NULL
cytokine	NULL
receptors	NULL
,	NULL
characterized	NULL
by	NULL
a	NULL
single	NULL
transmembrane	NULL
domain	NULL
and	NULL
an	NULL
extracellular	NULL
domain	NULL
with	NULL
four	NULL
common	NULL
cysteines	NULL
at	NULL
the	NULL
N-terminus	NULL
and	NULL
a	NULL
Trp-Ser-X-Trp-Ser	NULL
motif	NULL
at	NULL
the	NULL
C-terminus	NULL
which	NULL
is	NULL
required	NULL
for	NULL
activation	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
intracellular	NULL
domain	NULL
contains	NULL
no	NULL
tyrosine	NULL
kinase	NULL
domain	NULL
,	NULL
although	NULL
binding	NULL
of	NULL
Epo	NULL
results	NULL
in	NULL
increased	NULL
phosphorylation	NULL
of	NULL
EpoR	NULL
itself	NULL
and	NULL
other	NULL
cellular	NULL
proteins	NULL
.	NULL

JAK2	NULL
and	NULL
other	NULL
specific	NULL
non-receptor	NULL
tyrosine	NULL
kinases	NULL
have	NULL
been	NULL
associated	NULL
with	NULL
the	NULL
phosphorylation	NULL
activity	NULL
following	NULL
Epo	NULL
stimulation	NULL
(	NULL
2	NULL
)	NULL
.	NULL

We	NULL
and	NULL
others	NULL
have	NULL
previously	NULL
cloned	NULL
the	NULL
human	NULL
erythropoietin	NULL
receptor	NULL
(	NULL
hEpoR	NULL
)	NULL
gene	NULL
encoding	NULL
a	NULL
508	NULL
amino	NULL
acid	NULL
polypeptide	NULL
in	NULL
eight	NULL
exons	NULL
(	NULL
3-5	NULL
)	NULL
.	NULL

Our	NULL
analysis	NULL
of	NULL
a	NULL
15	NULL
kb	NULL
genomic	NULL
clone	NULL
containing	NULL
2	NULL
kb	NULL
of	NULL
5¢	NULL
flanking	NULL
sequence	NULL
indicated	NULL
that	NULL
this	NULL
5	NULL
region	NULL
could	NULL
provide	NULL
a	NULL
correctly	NULL
initiated	NULL
transcript	NULL
when	NULL
used	NULL
as	NULL
a	NULL
DNA	NULL
template	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
erythroid	NULL
cells	NULL
for	NULL
in	NULL
vitro	NULL
transcription	NULL
(	NULL
3	NULL
)	NULL
.	NULL

The	NULL
proximal	NULL
5	NULL
'	NULL
region	NULL
contains	NULL
binding	NULL
sites	NULL
for	NULL
transcription	NULL
factors	NULL
Spl	NULL
at	NULL
-17	NULL
bp	NULL
and	NULL
erythroid-specific	NULL
GATA-1	NULL
at	NULL
-45	NULL
bp	NULL
and	NULL
lacks	NULL
a	NULL
TATA	NULL
sequence	NULL
.	NULL

The	NULL
15	NULL
kb	NULL
cloned	NULL
hEpoR	NULL
gene	NULL
was	NULL
used	NULL
to	NULL
produce	NULL
transgenic	NULL
mice	NULL
which	NULL
expressed	NULL
hEpoR	NULL
in	NULL
adult	NULL
bone	NULL
marrow	NULL
and	NULL
spleen	NULL
,	NULL
but	NULL
not	NULL
in	NULL
heart	NULL
,	NULL
kidney	NULL
,	NULL
lung	NULL
and	NULL
liver	NULL
(	NULL
6	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
transcription	NULL
control	NULL
elements	NULL
within	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
sequence	NULL
of	NULL
hEpoR	NULL
we	NULL
used	NULL
deletion	NULL
analysis	NULL
and	NULL
transfection	NULL
assays	NULL
.	NULL

We	NULL
used	NULL
erythroid	NULL
cell	NULL
lines	NULL
OCIM1	NULL
and	NULL
K562	NULL
,	NULL
which	NULL
have	NULL
high	NULL
and	NULL
low	NULL
levels	NULL
of	NULL
hEpoR	NULL
on	NULL
their	NULL
cell	NULL
surface	NULL
respectively	NULL
,	NULL
as	NULL
model	NULL
systems	NULL
for	NULL
hEpoR	NULL
transcription	NULL
activation	NULL
(	NULL
7-10	NULL
)	NULL
.	NULL

We	NULL
describe	NULL
a	NULL
minimal	NULL
hEpoR	NULL
promoter	NULL
that	NULL
contains	NULL
binding	NULL
sites	NULL
for	NULL
transcription	NULL
factors	NULL
Spl	NULL
and	NULL
GATA-1	NULL
*	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
3042	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1995	NULL
,	NULL
Vol	NULL
.	NULL

23	NULL
,	NULL
No	NULL
.	NULL

15	NULL
and	NULL
that	NULL
reflects	NULL
the	NULL
high	NULL
and	NULL
low	NULL
levels	NULL
of	NULL
constitutive	NULL
hEpoR	NULL
transcription	NULL
activity	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
.	NULL

Protein	NULL
binding	NULL
studies	NULL
provide	NULL
evidence	NULL
of	NULL
multiple	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
Spl	NULL
and	NULL
GATA-1	NULL
binding	NULL
motifs	NULL
.	NULL

Data	NULL
are	NULL
presented	NULL
to	NULL
suggest	NULL
that	NULL
coordination	NULL
of	NULL
Spl	NULL
and	NULL
GATA-1	NULL
with	NULL
other	NULL
cellular	NULL
factors	NULL
act	NULL
to	NULL
provide	NULL
a	NULL
high	NULL
level	NULL
of	NULL
hEpoR	NULL
transcription	NULL
activation	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
culture	NULL
OCIM1	NULL
cells	NULL
(	NULL
11	NULL
)	NULL
were	NULL
maintained	NULL
in	NULL
alpha	NULL
minimal	NULL
essential	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
FBS	NULL
)	NULL
.	NULL

K562	NULL
cells	NULL
(	NULL
12	NULL
)	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FBS	NULL
.	NULL

HeLa	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
EMEM	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FBS	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
allowed	NULL
to	NULL
expand	NULL
in	NULL
an	NULL
atmosphere	NULL
of	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
.	NULL

Plasmid	NULL
construction	NULL
Plasmids	NULL
for	NULL
transfection	NULL
assays	NULL
of	NULL
promoter	NULL
strength	NULL
were	NULL
constructed	NULL
using	NULL
the	NULL
X/hol	NULL
and	NULL
HindIII	NULL
restriction	NULL
enzyme	NULL
sites	NULL
within	NULL
the	NULL
PGL2Basic	NULL
luciferase	NULL
plasmid	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

Insert	NULL
DNA	NULL
was	NULL
constructed	NULL
by	NULL
PCR	NULL
using	NULL
sequence-spe-cific	NULL
oligonucleotides	NULL
flanked	NULL
by	NULL
HindIII	NULL
and	NULL
Xhol	NULL
restriction	NULL
enzyme	NULL
sites	NULL
.	NULL

Fidelity	NULL
of	NULL
the	NULL
constructs	NULL
was	NULL
verified	NULL
by	NULL
restriction	NULL
enzyme	NULL
mapping	NULL
and	NULL
sequencing	NULL
of	NULL
the	NULL
junction	NULL
region	NULL
.	NULL

At	NULL
least	NULL
two	NULL
constructs	NULL
subcloned	NULL
for	NULL
each	NULL
deletion	NULL
mutant	NULL
consisting	NULL
of	NULL
>	NULL
445	NULL
bp	NULL
were	NULL
tested	NULL
.	NULL

Two	NULL
mutations	NULL
of	NULL
the	NULL
GATA-1	NULL
binding	NULL
motif	NULL
were	NULL
constructed	NULL
using	NULL
the	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
A194	NULL
(	NULL
containing	NULL
the	NULL
human	NULL
erythropoietin	NULL
receptor	NULL
promoter	NULL
extending	NULL
to	NULL
-194	NULL
bp	NULL
5	NULL
``	NULL
)	NULL
in	NULL
which	NULL
AGATAA	NULL
was	NULL
replaced	NULL
with	NULL
CTGCAG	NULL
(	NULL
Pstl	NULL
restriction	NULL
site	NULL
)	NULL
for	NULL
AGATA-a	NULL
and	NULL
with	NULL
CTCGAG	NULL
(	NULL
Xhol	NULL
restriction	NULL
site	NULL
)	NULL
for	NULL
AGATA-b	NULL
.	NULL

A	NULL
mutation	NULL
of	NULL
the	NULL
Spl	NULL
binding	NULL
motif	NULL
was	NULL
constructed	NULL
in	NULL
which	NULL
the	NULL
Spl	NULL
binding	NULL
motif	NULL
was	NULL
replaced	NULL
with	NULL
GGATCC	NULL
(	NULL
BamHI	NULL
restriction	NULL
site	NULL
)	NULL
.	NULL

Plasmid	NULL
pSVGH	NULL
(	NULL
SV40	NULL
promoter	NULL
linked	NULL
to	NULL
a	NULL
growth	NULL
hormone	NULL
reporter	NULL
gene	NULL
)	NULL
was	NULL
used	NULL
to	NULL
evaluate	NULL
transfection	NULL
efficiency	NULL
.	NULL

PGL2	NULL
Control	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
contained	NULL
the	NULL
simian	NULL
virus	NULL
(	NULL
SV40	NULL
)	NULL
promoter	NULL
and	NULL
enhancer	NULL
sequence	NULL
linked	NULL
to	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
,	NULL
while	NULL
the	NULL
PGL2	NULL
Basic	NULL
(	NULL
Promega	NULL
)	NULL
plasmid	NULL
contained	NULL
no	NULL
promoter	NULL
or	NULL
enhancer	NULL
sequences	NULL
.	NULL

The	NULL
eukaryotic	NULL
expression	NULL
vector	NULL
for	NULL
human	NULL
GATA-1	NULL
contained	NULL
a	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
(	NULL
RSV	NULL
)	NULL
promoter	NULL
linked	NULL
to	NULL
the	NULL
human	NULL
GATA-1	NULL
cDNA	NULL
.	NULL

An	NULL
Ay-globin	NULL
reporter	NULL
gene	NULL
construct	NULL
consisted	NULL
of	NULL
an	NULL
Ay-globin	NULL
promoter	NULL
fragment	NULL
extending	NULL
to	NULL
-160	NULL
bp	NULL
5¢	NULL
of	NULL
the	NULL
cap	NULL
site	NULL
linked	NULL
to	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
.	NULL

Transient	NULL
transfection	NULL
analysis	NULL
Transfection	NULL
of	NULL
plasmid	NULL
DNA	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
electroporation	NULL
(	NULL
Gene	NULL
Pulser	NULL
;	NULL
BioRad	NULL
Laboratories	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
constructs	NULL
were	NULL
co-transfected	NULL
with	NULL
plasmid	NULL
pSVGH	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
for	NULL
48	NULL
h	NULL
in	NULL
appropriate	NULL
media	NULL
.	NULL

Luciferase	NULL
assays	NULL
were	NULL
performed	NULL
by	NULL
direct	NULL
lysis	NULL
of	NULL
cells	NULL
in	NULL
lysing	NULL
buffer	NULL
containing	NULL
acetylCoA	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
and	NULL
assay	NULL
of	NULL
the	NULL
supernatant	NULL
for	NULL
luciferase	NULL
activity	NULL
using	NULL
a	NULL
Luminometer	NULL
(	NULL
Analytical	NULL
Luminescence	NULL
Laboratory	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Growth	NULL
hormone	NULL
was	NULL
quantitated	NULL
by	NULL
radioimmu-noassay	NULL
using	NULL
'	NULL
»	NULL
``	NULL
I-labeled	NULL
anti-growth	NULL
hormone	NULL
antibody	NULL
(	NULL
Nichols	NULL
Institute	NULL
,	NULL
San	NULL
Juan	NULL
Capistrano	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
Cellular	NULL
mRNA	NULL
was	NULL
prepared	NULL
using	NULL
an	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
column	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

For	NULL
Northern	NULL
blot	NULL
analysis	NULL
2	NULL
pug/lane	NULL
mRNA	NULL
were	NULL
loaded	NULL
on	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
containing	NULL
2.2	NULL
M	NULL
formaldehyde	NULL
.	NULL

The	NULL
mRNAs	NULL
blotted	NULL
onto	NULL
Nytran	NULL
(	NULL
Schieicher	NULL
&	NULL
Schuell	NULL
Inc.	NULL
,	NULL
Keene	NULL
,	NULL
NH	NULL
)	NULL
filters	NULL
were	NULL
hybridized	NULL
with	NULL
a	NULL
random	NULL
primed	NULL
*2P-labeled	NULL
cDNA	NULL
probe	NULL
for	NULL
GATA-1	NULL
and	NULL
f-actin	NULL
.	NULL

Hybridization	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
10	NULL
%	NULL
dextran	NULL
sulfate	NULL
,	NULL
1	NULL
%	NULL
SDS	NULL
at	NULL
42°C	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
The	NULL
gel	NULL
mobility	NULL
shift	NULL
assay	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
OCIM1	NULL
and	NULL
HeLa	NULL
continuous	NULL
cell	NULL
lines	NULL
were	NULL
prepared	NULL
following	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
15	NULL
)	NULL
.	NULL

Double-stranded	NULL
synthetic	NULL
DNA	NULL
fragments	NULL
were	NULL
used	NULL
as	NULL
probes	NULL
and	NULL
DNA	NULL
competitors	NULL
.	NULL

Oligonucleotides	NULL
were	NULL
synthesized	NULL
on	NULL
an	NULL
Applied	NULL
Biosystems	NULL
308B	NULL
DNA	NULL
synthesizer	NULL
(	NULL
Foster	NULL
City	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Complementary	NULL
strands	NULL
were	NULL
annealed	NULL
at	NULL
65°C	NULL
for	NULL
5	NULL
min	NULL
and	NULL
the	NULL
resultant	NULL
double-stranded	NULL
DNA	NULL
fragments	NULL
were	NULL
gel	NULL
purified	NULL
.	NULL

The	NULL
DNA	NULL
probes	NULL
were	NULL
P-labeled	NULL
at	NULL
the	NULL
5'-ends	NULL
using	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
.	NULL

The	NULL
binding	NULL
reaction	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
15	NULL
pl	NULL
containing	NULL
0-10	NULL
ug	NULL
OCIM1	NULL
or	NULL
HeLa	NULL
cell	NULL
nuclear	NULL
extract	NULL
,	NULL
1	NULL
ug	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
and	NULL
specific	NULL
competitor	NULL
DNA	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
binding	NULL
buffer	NULL
was	NULL
the	NULL
same	NULL
as	NULL
that	NULL
used	NULL
for	NULL
DNase	NULL
I	NULL
footprinting	NULL
assays	NULL
(	NULL
see	NULL
below	NULL
)	NULL
and	NULL
consisted	NULL
of	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
48	NULL
mM	NULL
KCI	NULL
,	NULL
0.04	NULL
mM	NULL
EDTA	NULL
,	NULL
8	NULL
mM	NULL
MgCl	NULL
;	NULL
with	NULL
protease	NULL
inhibitors	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
In	NULL
vitro	NULL
DNase	NULL
I	NULL
footprinting	NULL
was	NULL
performed	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Briggs	NULL
et	NULL
al	NULL
.	NULL

(	NULL
16	NULL
)	NULL
with	NULL
the	NULL
following	NULL
modification	NULL
.	NULL

The	NULL
DNA	NULL
probes	NULL
were	NULL
constructed	NULL
using	NULL
PCR-amplified	NULL
DNA	NULL
to	NULL
generate	NULL
a	NULL
DNA	NULL
fragment	NULL
extending	NULL
from	NULL
-250	NULL
to	NULL
-24	NULL
bp	NULL
5	NULL
of	NULL
the	NULL
cap	NULL
site	NULL
for	NULL
the	NULL
human	NULL
erythropoietin	NULL
receptor	NULL
gene	NULL
and	NULL
another	NULL
probe	NULL
extending	NULL
from	NULL
-136	NULL
bp	NULL
5°	NULL
to	NULL
+66	NULL
bp	NULL
3	NULL
'	NULL
of	NULL
the	NULL
cap	NULL
site	NULL
.	NULL

Labeling	NULL
of	NULL
the	NULL
sense	NULL
or	NULL
antisense	NULL
strand	NULL
of	NULL
the	NULL
probe	NULL
was	NULL
achieved	NULL
by	NULL
using	NULL
the	NULL
appropriately	NULL
*	NULL
>	NULL
P-labeled	NULL
primer	NULL
.	NULL

Aliquots	NULL
of	NULL
probe	NULL
(	NULL
20	NULL
000	NULL
c.p.m	NULL
.	NULL
)	NULL

and	NULL
nuclear	NULL
extract	NULL
(	NULL
50-100	NULL
ug	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
30°C	NULL
in	NULL
the	NULL
binding	NULL
buffer	NULL
described	NULL
above	NULL
for	NULL
gel	NULL
mobility	NULL
shift	NULL
assay	NULL
with	NULL
2	NULL
ug	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
(	NULL
1	NULL
U	NULL
)	NULL
was	NULL
added	NULL
on	NULL
ice	NULL
and	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
1	NULL
min	NULL
.	NULL

DNase	NULL
I	NULL
activity	NULL
was	NULL
stopped	NULL
by	NULL
addition	NULL
of	NULL
1	NULL
vol	NULL
50	NULL
mM	NULL
EDTA	NULL
with	NULL
0.2	NULL
%	NULL
SDS	NULL
,	NULL
100	NULL
ug/ml	NULL
tRNA	NULL
and	NULL
500	NULL
ug/ml	NULL
proteinase	NULL
K	NULL
and	NULL
incubated	NULL
at	NULL
55°C	NULL
for	NULL
1	NULL
h.	NULL
After	NULL
phenol/chloroform	NULL
extraction	NULL
and	NULL
ethanol	NULL
precipitation	NULL
the	NULL
sample	NULL
was	NULL
resuspended	NULL
in	NULL
loading	NULL
buffer	NULL
containing	NULL
90	NULL
%	NULL
formamide	NULL
and	NULL
analyzed	NULL
on	NULL
a	NULL
6	NULL
%	NULL
acrylamide-7	NULL
M	NULL
urea	NULL
sequencing	NULL
gel	NULL
.	NULL

RESULTS	NULL
Functional	NULL
analysis	NULL
of	NULL
the	NULL
EpoR	NULL
5	NULL
flanking	NULL
region	NULL
As	NULL
model	NULL
systems	NULL
we	NULL
used	NULL
erythroid	NULL
cell	NULL
lines	NULL
OCIM1	NULL
and	NULL
K562	NULL
and	NULL
non-erythroid	NULL
HeLa	NULL
cells	NULL
.	NULL

OCIM1	NULL
cells	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
hEpoR	NULL
,	NULL
with	NULL
3000	NULL
Epo	NULL
binding	NULL
sites	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
(	NULL
7	NULL
)	NULL
.	NULL

In	NULL
K562	NULL
cells	NULL
the	NULL
hEpoR	NULL
gene	NULL
is	NULL
active	NULL
,	NULL
but	NULL
only	NULL
at	NULL
low	NULL
levels	NULL
,	NULL
with	NULL
only	NULL
a	NULL
few	NULL
Epo	NULL
binding	NULL
sites	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
(	NULL
8,9	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
hEpoR	NULL
mRNA	NULL
transcripts	NULL
in	NULL
OCIM1	NULL
cells	NULL
(	NULL
4.8	NULL
x	NULL
107	NULL
ng/ug	NULL
mRNA	NULL
)	NULL
is	NULL
at	NULL
least	NULL
one	NULL
order	NULL
of	NULL
magnitude	NULL
higher	NULL
than	NULL
the	NULL
level	NULL
of	NULL
hEpoR	NULL
mRNA	NULL
transcripts	NULL
in	NULL
K562	NULL
cells	NULL
(	NULL
2.3	NULL
x	NULL
10+	NULL
ng/ug	NULL
mRNA	NULL
)	NULL
(	NULL
10	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
hEpoR	NULL
expression	NULL
is	NULL
reflected	NULL
,	NULL
in	NULL
part	NULL
,	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
in	NULL
OCIM1	NULL
and	NULL
K562	NULL
cells	NULL
.	NULL

The	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
hEpoR	NULL
gene	NULL
was	NULL
analyzed	NULL
using	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
and	NULL
transient	NULL
transfection	NULL
assays	NULL
to	NULL
identify	NULL
elements	NULL
contributing	NULL
to	NULL
specific	NULL
hEpoR	NULL
gene	NULL
expression	NULL
.	NULL

A	NULL
series	NULL
of	NULL
deletion	NULL
mutation	NULL
constructs	NULL
,	NULL
A1778	NULL
,	NULL
A937	NULL
,	NULL
A445	NULL
,	NULL
A150	NULL
and	NULL
A+2	NULL
,	NULL
was	NULL
made	NULL
extending	NULL
5	NULL
'	NULL
to	NULL
-1778	NULL
,	NULL
-937	NULL
,	NULL
-445	NULL
and	NULL
-150	NULL
bp	NULL
upstream	NULL
and	NULL
+2	NULL
bp	NULL
downstream	NULL
from	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
longest	NULL
construct	NULL
(	NULL
A1778	NULL
)	NULL
includes	NULL
five	NULL
CACCC	NULL
motifs	NULL
located	NULL
at	NULL
-451	NULL
,	NULL
-1571	NULL
and	NULL
-1772	NULL
bp	NULL
and	NULL
at	NULL
-465	NULL
and	NULL
-799	NULL
bp	NULL
in	NULL
the	NULL
antisense	NULL
direction	NULL
5	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
,	NULL
with	NULL
an	NULL
additional	NULL
CACCC	NULL
motif	NULL
in	NULL
the	NULL
antisense	NULL
direction	NULL
at	NULL
+84	NULL
bp	NULL
in	NULL
the	NULL
transcribed	NULL
untranslated	NULL
region	NULL
of	NULL
the	NULL
hEpoR	NULL
gene	NULL
.	NULL

The	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
hEpoR	NULL
gene	NULL
also	NULL
contains	NULL
extensive	NULL
homology	NULL
to	NULL
Alu	NULL
repeat	NULL
sequences	NULL
and	NULL
a	NULL
purine-rich	NULL
region	NULL
of	NULL
123	NULL
bp	NULL
consisting	NULL
only	NULL
of	NULL
Gs	NULL
and	NULL
As	NULL
extending	NULL
from	NULL
-322	NULL
to	NULL
444	NULL
bp	NULL
.	NULL

The	NULL
5°	NULL
CACCC	NULL
motifs	NULL
and	NULL
purine-rich	NULL
region	NULL
were	NULL
deleted	NULL
in	NULL
the	NULL
A150	NULL
construct	NULL
,	NULL
which	NULL
retains	NULL
the	NULL
binding	NULL
motifs	NULL
for	NULL
GATA-1	NULL
and	NULL
Spl	NULL
transcription	NULL
factors	NULL
.	NULL

All	NULL
transient	NULL
transfection	NULL
assays	NULL
with	NULL
these	NULL
hEpoR	NULL
deletion	NULL
constructs	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
co-transfection	NULL
of	NULL
pSVGH	NULL
and	NULL
the	NULL
activity	NULL
of	NULL
growth	NULL
hormone	NULL
was	NULL
quantitated	NULL
and	NULL
used	NULL
to	NULL
determine	NULL
transfection	NULL
efficiency	NULL
.	NULL

The	NULL
hEpoR	NULL
reporter	NULL
gene	NULL
constructs	NULL
were	NULL
most	NULL
active	NULL
in	NULL
OCIMI1	NULL
cells	NULL
with	NULL
a	NULL
high	NULL
level	NULL
of	NULL
endogenous	NULL
hEpoR	NULL
activity	NULL
,	NULL
compared	NULL
with	NULL
K562	NULL
and	NULL
non-erythroid	NULL
HeLa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
reflecting	NULL
the	NULL
lower	NULL
or	NULL
absent	NULL
activity	NULL
of	NULL
the	NULL
endogenous	NULL
hEpoR	NULL
gene	NULL
in	NULL
K562	NULL
cells	NULL
and	NULL
HeLa	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
relative	NULL
transcription	NULL
activities	NULL
of	NULL
the	NULL
A1778	NULL
,	NULL
A937	NULL
,	NULL
A445	NULL
and	NULL
A150	NULL
constructs	NULL
suggested	NULL
regions	NULL
of	NULL
positive	NULL
and	NULL
negative	NULL
regulation	NULL
.	NULL

The	NULL
A937	NULL
construct	NULL
fell	NULL
to	NULL
75	NULL
%	NULL
(	NULL
P	NULL
=	NULL
0.028	NULL
)	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
A1778	NULL
construct	NULL
in	NULL
OCIM1	NULL
cells	NULL
,	NULL
suggesting	NULL
a	NULL
potential	NULL
region	NULL
of	NULL
positive	NULL
regulation	NULL
;	NULL
the	NULL
regions	NULL
between	NULL
-937	NULL
and	NULL
-445	NULL
bp	NULL
and	NULL
between	NULL
-445	NULL
and	NULL
150	NULL
bp	NULL
exhibited	NULL
some	NULL
negative	NULL
regulation	NULL
and	NULL
the	NULL
activity	NULL
of	NULL
A150	NULL
was	NULL
2-fold	NULL
greater	NULL
than	NULL
the	NULL
activity	NULL
of	NULL
A937	NULL
(	NULL
P	NULL
=0.002	NULL
)	NULL
.	NULL

A150	NULL
was	NULL
the	NULL
hEpoR	NULL
construct	NULL
with	NULL
the	NULL
greatest	NULL
level	NULL
of	NULL
activity	NULL
.	NULL

The	NULL
A+2	NULL
construct	NULL
without	NULL
any	NULL
5	NULL
``	NULL
flanking	NULL
sequence	NULL
exhibited	NULL
no	NULL
transcription	NULL
activation	NULL
.	NULL

These	NULL
constructs	NULL
exhibited	NULL
a	NULL
similar	NULL
relative	NULL
behavior	NULL
in	NULL
K562	NULL
cells	NULL
,	NULL
but	NULL
with	NULL
a	NULL
lower	NULL
level	NULL
of	NULL
activity	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
150	NULL
bp	NULL
5	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
can	NULL
function	NULL
as	NULL
a	NULL
proximal	NULL
promoter	NULL
for	NULL
transcription	NULL
activation	NULL
of	NULL
the	NULL
hEpoR	NULL
gene	NULL
in	NULL
erythroid	NULL
OCIM1	NULL
and	NULL
K562	NULL
cells	NULL
and	NULL
may	NULL
be	NULL
erythroid	NULL
specific	NULL
.	NULL

In	NULL
non-erythroid	NULL
HeLa	NULL
cells	NULL
the	NULL
relative	NULL
activity	NULL
of	NULL
the	NULL
hEpoR	NULL
constructs	NULL
did	NULL
not	NULL
follow	NULL
the	NULL
behavior	NULL
of	NULL
that	NULL
observed	NULL
for	NULL
erythroid	NULL
OCIM1	NULL
or	NULL
K562	NULL
cells	NULL
and	NULL
appeared	NULL
to	NULL
depend	NULL
on	NULL
the	NULL
length	NULL
of	NULL
the	NULL
5¢	NULL
flanking	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
greatest	NULL
activity	NULL
was	NULL
observed	NULL
with	NULL
the	NULL
longest	NULL
construct	NULL
,	NULL
A1778	NULL
.	NULL

The	NULL
activities	NULL
observed	NULL
for	NULL
A937	NULL
and	NULL
A445	NULL
were	NULL
half	NULL
that	NULL
obtained	NULL
for	NULL
A1778	NULL
(	NULL
P	NULL
=	NULL
0.005	NULL
and	NULL
P	NULL
=	NULL
0.009	NULL
,	NULL
respectively	NULL
)	NULL
and	NULL
the	NULL
activity	NULL
of	NULL
A150	NULL
was	NULL
~5-fold	NULL
lower	NULL
than	NULL
that	NULL
obtained	NULL
for	NULL
A1778	NULL
(	NULL
P	NULL
<	NULL
0.001	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
transcription	NULL
activity	NULL
decreased	NULL
to	NULL
baseline	NULL
levels	NULL
for	NULL
the	NULL
A+2	NULL
construct	NULL
,	NULL
which	NULL
lacks	NULL
5	NULL
``	NULL
flanking	NULL
sequence	NULL
.	NULL

Transactivation	NULL
of	NULL
the	NULL
hEpoR	NULL
promoter	NULL
by	NULL
GATA-1	NULL
The	NULL
prominent	NULL
feature	NULL
of	NULL
the	NULL
A150	NULL
construct	NULL
is	NULL
the	NULL
presence	NULL
of	NULL
binding	NULL
motifs	NULL
for	NULL
transcription	NULL
factors	NULL
GATA-1	NULL
and	NULL
Spl	NULL
.	NULL

GATA-1	NULL
exhibits	NULL
erythroid	NULL
specificity	NULL
and	NULL
is	NULL
associated	NULL
with	NULL
transcription	NULL
activation	NULL
of	NULL
several	NULL
erythroid-specific	NULL
genes	NULL
,	NULL
including	NULL
globin	NULL
(	NULL
17	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
ability	NULL
of	NULL
GATA-1	NULL
to	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1995	NULL
,	NULL
Vol	NULL
.	NULL

23	NULL
,	NULL
No	NULL
.	NULL

15	NULL
3043	NULL
Purine	NULL
.GA_AL	NULL
``	NULL
A.	NULL
Alu	NULL
family	NULL
Alu	NULL
family	NULL
rich	NULL
_	NULL
cafa-1	NULL
Spt	NULL
L___	NULL
cacee	NULL
cacee	NULL
ceara	NULL
ceetTe	NULL
cacee	NULL
_	NULL
+2000	NULL
+1500	NULL
+1000	NULL
-500	NULL
£1	NULL
Tm	NULL
+177	NULL
j	NULL
~937	NULL
~445	NULL
A445	NULL
+150	NULL
A150	NULL
+2	NULL
me	NULL
A42	NULL
B	NULL
0.6	NULL
Relative	NULL
activity	NULL
{	NULL
normalized	NULL
to	NULL
SV40	NULL
)	NULL
0	NULL
t	NULL
A1778	NULL
A987	NULL
A445	NULL
|	NULL
A150	NULL
-	NULL
A+2	NULL
-	NULL
control	NULL
K562	NULL
0.1	NULL
[	NULL
i	NULL
i	NULL
i	NULL
7	NULL
0	NULL
A1778	NULL
A937	NULL
A445	NULL
A150	NULL
-	NULL
A+2	NULL
control	NULL
HeLa	NULL
Relative	NULL
activity	NULL
-	NULL
Relative	NULL
activity	NULL
0	NULL
t	NULL
A1778	NULL
A987	NULL
A445	NULL
A150	NULL
-	NULL
A+2	NULL
-	NULL
control	NULL
C	NULL
,	NULL
.	NULL

.	NULL

sf	NULL
hepor	NULL
7	NULL
6	NULL
5	NULL
}	NULL
5	NULL
3	NULL
©	NULL
$	NULL
4	NULL
$	NULL
4	NULL
£3	NULL
23	NULL
3B	NULL
3	NULL
32	NULL
3	NULL
2	NULL
1	NULL
1	NULL
o	NULL
i	NULL
1	NULL
L	NULL
o	NULL
L	NULL
1	NULL
T	NULL
40	NULL
0	NULL
20	NULL
_	NULL
30	NULL
40	NULL
10	NULL
_	NULL
20	NULL
_	NULL
30	NULL
10	NULL
RSVGATA-1	NULL
(	NULL
ng	NULL
)	NULL
RSVGATA-1	NULL
(	NULL
1g	NULL
)	NULL
Figure	NULL
1	NULL
.	NULL

Transient	NULL
transfection	NULL
assay	NULL
of	NULL
the	NULL
hEpoR	NULL
5	NULL
'	NULL
region	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Human	NULL
EpoR	NULL
gene	NULL
fragments	NULL
extend	NULL
5	NULL
``	NULL
to	NULL
-1778	NULL
(	NULL
A1778	NULL
)	NULL
,	NULL
-937	NULL
(	NULL
A937	NULL
)	NULL
,	NULL
-445	NULL
p	NULL
(	NULL
A445	NULL
)	NULL
,	NULL
-150	NULL
(	NULL
A150	NULL
)	NULL
and	NULL
+2	NULL
bp	NULL
(	NULL
A+2	NULL
)	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
were	NULL
used	NULL
in	NULL
luciferase	NULL
reporter	NULL
gene	NULL
constructs	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
hEpoR	NULL
reporter	NULL
gene	NULL
constructs	NULL
were	NULL
assayed	NULL
in	NULL
the	NULL
erythroid	NULL
OCIM	NULL
1	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
and	NULL
K562	NULL
(	NULL
middle	NULL
panel	NULL
)	NULL
cell	NULL
lines	NULL
and	NULL
the	NULL
non-erythroid	NULL
HeLa	NULL
cell	NULL
line	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Data	NULL
normalized	NULL
to	NULL
SV40	NULL
promoter	NULL
activity	NULL
are	NULL
plotted	NULL
.	NULL

The	NULL
control	NULL
construct	NULL
contains	NULL
no	NULL
promoter	NULL
.	NULL

(	NULL
Mean	NULL
SV40	NULL
promoter	NULL
activities	NULL
were	NULL
5041	NULL
,	NULL
20	NULL
607	NULL
and	NULL
25	NULL
000	NULL
relative	NULL
luciferase	NULL
units	NULL
in	NULL
OCIM1	NULL
,	NULL
K562	NULL
and	NULL
HeLa	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL
)	NULL

(	NULL
C	NULL
)	NULL
Increasing	NULL
amounts	NULL
of	NULL
RSV-GATA-1	NULL
expression	NULL
plasmid	NULL
were	NULL
co-transfected	NULL
with	NULL
the	NULL
hEpoR	NULL
A150	NULL
or	NULL
human	NULL
Ay-globin	NULL
reporter	NULL
gene	NULL
constructs	NULL
.	NULL

Data	NULL
are	NULL
normalized	NULL
to	NULL
activity	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
RSV-GATA-1	NULL
.	NULL

Constructs	NULL
were	NULL
assayed	NULL
in	NULL
OCIM	NULL
1	NULL
(	NULL
squares	NULL
)	NULL
,	NULL
K562	NULL
(	NULL
circles	NULL
)	NULL
and	NULL
HeLa	NULL
(	NULL
x	NULL
)	NULL
cells	NULL
.	NULL

(	NULL
The	NULL
relative	NULL
activities	NULL
of	NULL
the	NULL
Ay-globin	NULL
promoter	NULL
in	NULL
OCIM1	NULL
,	NULL
K562	NULL
and	NULL
HeLa	NULL
cells	NULL
without	NULL
RSV-GATA-1	NULL
were	NULL
0.8	NULL
,	NULL
0.1	NULL
and	NULL
0.1	NULL
of	NULL
the	NULL
SV40	NULL
promoter	NULL
,	NULL
respectively	NULL
.	NULL
)	NULL

transactivate	NULL
the	NULL
EpoR	NULL
promoter	NULL
we	NULL
co-transfected	NULL
an	NULL
expression	NULL
vector	NULL
for	NULL
the	NULL
human	NULL
GATA-1	NULL
protein	NULL
(	NULL
RSV-GATA-1	NULL
)	NULL
with	NULL
the	NULL
hEpoR	NULL
reporter	NULL
gene	NULL
constructs	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

An	NULL
expression	NULL
plasmid	NULL
containing	NULL
RSV-CAT	NULL
was	NULL
used	NULL
to	NULL
maintain	NULL
a	NULL
constant	NULL
level	NULL
of	NULL
DNA	NULL
in	NULL
these	NULL
co-transfection	NULL
experiments	NULL
.	NULL

In	NULL
erythroid	NULL
K562	NULL
cells	NULL
increasing	NULL
GATA-1	NULL
resulted	NULL
in	NULL
transcription	NULL
activation	NULL
of	NULL
the	NULL
hEpoR	NULL
promoter	NULL
up	NULL
to	NULL
S-fold	NULL
.	NULL

Transactivation	NULL
appeared	NULL
to	NULL
saturate	NULL
as	NULL
the	NULL
amount	NULL
of	NULL
RSV-GATA-1	NULL
increased	NULL
beyond	NULL
10	NULL
ug/reaction	NULL
.	NULL

Increasing	NULL
GATA-1	NULL
levels	NULL
in	NULL
non-erythroid	NULL
HeLa	NULL
cells	NULL
resulted	NULL
in	NULL
transactivation	NULL
of	NULL
the	NULL
hEpoR	NULL
promoter	NULL
by	NULL
2-fold	NULL
or	NULL
greater	NULL
.	NULL

Surprisingly	NULL
,	NULL
in	NULL
erythroid	NULL
OCIM	NULL
1	NULL
cells	NULL
with	NULL
high	NULL
levels	NULL
of	NULL
constitutive	NULL
hEpoR	NULL
expression	NULL
(	NULL
7,10	NULL
)	NULL
and	NULL
in	NULL
which	NULL
the	NULL
hEpoR	NULL
3044	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1995	NULL
,	NULL
Vol	NULL
.	NULL

23	NULL
,	NULL
No	NULL
.	NULL

15	NULL
promoter	NULL
exhibits	NULL
high	NULL
activity	NULL
,	NULL
increasing	NULL
GATA-1	NULL
levels	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
hEpoR	NULL
promoter	NULL
activity	NULL
.	NULL

Co-transfection	NULL
with	NULL
the	NULL
A1778	NULL
hEpoR	NULL
construct	NULL
with	NULL
RSV-GATA-1	NULL
also	NULL
produced	NULL
no	NULL
increase	NULL
in	NULL
transcription	NULL
activity	NULL
in	NULL
OCIM1	NULL
cells	NULL
,	NULL
but	NULL
increased	NULL
transcription	NULL
activity	NULL
in	NULL
K562	NULL
and	NULL
HeLa	NULL
cells	NULL
,	NULL
comparable	NULL
with	NULL
results	NULL
obtained	NULL
with	NULL
A150	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
when	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
hEpoR	NULL
promoter	NULL
is	NULL
low	NULL
,	NULL
increasing	NULL
GATA-1	NULL
expression	NULL
is	NULL
able	NULL
to	NULL
transactivate	NULL
the	NULL
hEpoR	NULL
promoter	NULL
and	NULL
that	NULL
transactivation	NULL
by	NULL
GATA-1	NULL
appears	NULL
to	NULL
saturate	NULL
.	NULL

Although	NULL
an	NULL
Sp1	NULL
binding	NULL
motif	NULL
is	NULL
also	NULL
contained	NULL
within	NULL
the	NULL
hEpoR	NULL
proximal	NULL
promoter	NULL
,	NULL
co-transfection	NULL
with	NULL
an	NULL
Spl	NULL
expression	NULL
vector	NULL
did	NULL
not	NULL
further	NULL
increase	NULL
hEpoR	NULL
activity	NULL
in	NULL
either	NULL
K562	NULL
or	NULL
OCIM1	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
the	NULL
transactivation	NULL
behavior	NULL
of	NULL
GATA-1	NULL
for	NULL
the	NULL
hEpoR	NULL
promoter	NULL
in	NULL
K562	NULL
and	NULL
OCIM	NULL
1	NULL
cells	NULL
was	NULL
promoter	NULL
specific	NULL
we	NULL
repeated	NULL
the	NULL
experiment	NULL
with	NULL
another	NULL
erythroid-specific	NULL
promoter	NULL
,	NULL
a	NULL
minimal	NULL
Ay-globin	NULL
promoter	NULL
extending	NULL
to	NULL
-160	NULL
bp	NULL
5°	NULL
of	NULL
the	NULL
cap	NULL
site	NULL
,	NULL
which	NULL
also	NULL
contains	NULL
a	NULL
GATA-1	NULL
binding	NULL
site	NULL
.	NULL

Co-transfection	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
RSV-GATA-1	NULL
was	NULL
able	NULL
to	NULL
increase	NULL
Ay-globin	NULL
promoter	NULL
activity	NULL
in	NULL
both	NULL
K562	NULL
and	NULL
OCIM1	NULL
cells	NULL
by	NULL
up	NULL
to	NULL
5-	NULL
and	NULL
2-fold	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

The	NULL
inability	NULL
of	NULL
GATA-1	NULL
to	NULL
transactivate	NULL
the	NULL
hEpoR	NULL
promoter	NULL
in	NULL
OCIM1	NULL
cells	NULL
appears	NULL
to	NULL
be	NULL
specific	NULL
for	NULL
hEpoR	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
GATA-1	NULL
mRNA	NULL
in	NULL
OCIM1	NULL
and	NULL
K562	NULL
cells	NULL
indicated	NULL
that	NULL
the	NULL
ratio	NULL
of	NULL
GATA-1	NULL
mRNA	NULL
in	NULL
K562	NULL
cells	NULL
to	NULL
OCIM1	NULL
cells	NULL
was	NULL
1.09	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
that	NULL
the	NULL
RSV-GATA-1	NULL
expression	NULL
vector	NULL
was	NULL
active	NULL
in	NULL
both	NULL
K562	NULL
and	NULL
OCIM1	NULL
cells	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
differences	NULL
observed	NULL
in	NULL
hEpoR	NULL
promoter	NULL
activity	NULL
between	NULL
K562	NULL
and	NULL
OCIM1	NULL
cells	NULL
can	NULL
not	NULL
be	NULL
attributed	NULL
to	NULL
differences	NULL
in	NULL
GATA-1	NULL
levels	NULL
alone	NULL
.	NULL

Protein	NULL
binding	NULL
to	NULL
the	NULL
hEpoR	NULL
promoter	NULL
To	NULL
identify	NULL
possible	NULL
control	NULL
elements	NULL
within	NULL
the	NULL
hEpoR	NULL
promoter	NULL
,	NULL
we	NULL
determined	NULL
regions	NULL
of	NULL
DNA	NULL
which	NULL
could	NULL
bind	NULL
to	NULL
nuclear	NULL
proteins	NULL
.	NULL

For	NULL
DNase	NULL
I	NULL
footprinting	NULL
we	NULL
used	NULL
a	NULL
P-labeled	NULL
DNA	NULL
probe	NULL
beginning	NULL
at	NULL
-236	NULL
bp	NULL
5	NULL
'	NULL
of	NULL
the	NULL
cap	NULL
site	NULL
extending	NULL
3	NULL
'	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
erythroid	NULL
OCIM1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

A	NULL
region	NULL
around	NULL
-175	NULL
was	NULL
protected	NULL
from	NULL
DNase	NULL
I	NULL
digestion	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
region	NULL
containing	NULL
an	NULL
AP2	NULL
site	NULL
located	NULL
at	NULL
-101	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
the	NULL
-175	NULL
region	NULL
did	NULL
not	NULL
reveal	NULL
any	NULL
homology	NULL
with	NULL
other	NULL
known	NULL
protein	NULL
binding	NULL
consensus	NULL
sequences	NULL
.	NULL

A	NULL
second	NULL
grobe	NULL
beginning	NULL
at	NULL
-136	NULL
bp	NULL
5	NULL
``	NULL
of	NULL
the	NULL
cap	NULL
site	NULL
and	NULL
labeled	NULL
with	NULL
*°P	NULL
was	NULL
used	NULL
to	NULL
examine	NULL
the	NULL
binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
in	NULL
the	NULL
region	NULL
around	NULL
the	NULL
Spl	NULL
and	NULL
GATA-1	NULL
binding	NULL
sites	NULL
.	NULL

Incubation	NULL
of	NULL
probe	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
OCIM1	NULL
cells	NULL
followed	NULL
by	NULL
treatment	NULL
with	NULL
DNase	NULL
I	NULL
revealed	NULL
a	NULL
region	NULL
of	NULL
protection	NULL
around	NULL
the	NULL
GATA-1	NULL
binding	NULL
site	NULL
.	NULL

The	NULL
DNase	NULL
I	NULL
footprint	NULL
generated	NULL
with	NULL
OCIM1	NULL
nuclear	NULL
extracts	NULL
also	NULL
showed	NULL
protection	NULL
in	NULL
the	NULL
region	NULL
containing	NULL
the	NULL
Spl	NULL
binding	NULL
site	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
footprinted	NULL
region	NULL
around	NULL
-175	NULL
bp	NULL
and	NULL
the	NULL
region	NULL
containing	NULL
the	NULL
AP2	NULL
site	NULL
at	NULL
-101	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
GATA-1	NULL
and	NULL
Spl	NULL
sites	NULL
may	NULL
function	NULL
as	NULL
protein	NULL
binding	NULL
regions	NULL
in	NULL
vivo	NULL
and	NULL
are	NULL
possible	NULL
candidates	NULL
for	NULL
transcription	NULL
regulatory	NULL
regions	NULL
.	NULL

Protein	NULL
binding	NULL
to	NULL
Sp1	NULL
and	NULL
GATA-1	NULL
binding	NULL
motifs	NULL
To	NULL
characterize	NULL
further	NULL
the	NULL
binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
Spl	NULL
and	NULL
GATA-1	NULL
binding	NULL
motifs	NULL
we	NULL
used	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
with	NULL
a	NULL
DNA	NULL
probe	NULL
extending	NULL
from	NULL
-63	NULL
bp	NULL
5	NULL
``	NULL
to	NULL
+1	NULL
bp	NULL
3	NULL
'	NULL
of	NULL
the	NULL
cap	NULL
site	NULL
.	NULL

When	NULL
the	NULL
°P-labeled	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
OCIM1	NULL
nuclear	NULL
extract	NULL
and	NULL
analyzed	NULL
by	NULL
gel	NULL
electrophoresis	NULL
we	NULL
identified	NULL
Figure	NULL
2	NULL
.	NULL

/n	NULL
vitro	NULL
footprinting	NULL
of	NULL
the	NULL
hEpoR	NULL
proximal	NULL
promoter	NULL
.	NULL

Probes	NULL
from	NULL
the	NULL
hEpoR	NULL
proximal	NULL
promoter	NULL
extending	NULL
from	NULL
-250	NULL
to	NULL
-24	NULL
bp	NULL
(	NULL
A	NULL
)	NULL
and	NULL
from	NULL
-136	NULL
to	NULL
+66	NULL
bp	NULL
(	NULL
B	NULL
)	NULL
relative	NULL
to	NULL
the	NULL
cap	NULL
site	NULL
were	NULL
*2P-labeled	NULL
at	NULL
the	NULL
5'-end	NULL
(	NULL
C	NULL
)	NULL
.	NULL

Probes	NULL
were	NULL
incubated	NULL
with	NULL
OCIM1	NULL
(	NULL
OCIM-1	NULL
)	NULL
nuclear	NULL
extract	NULL
followed	NULL
by	NULL
DNase	NULL
I	NULL
digestion	NULL
.	NULL

P	NULL
indicates	NULL
probe	NULL
alone	NULL
;	NULL
M	NULL
indicates	NULL
the	NULL
M13	NULL
sequencing	NULL
marker	NULL
.	NULL

Regions	NULL
containing	NULL
binding	NULL
sites	NULL
for	NULL
GATA-1	NULL
(	NULL
GATA-1	NULL
)	NULL
,	NULL
AP2	NULL
(	NULL
AP2	NULL
)	NULL
and	NULL
Spl	NULL
(	NULL
SP1	NULL
)	NULL
and	NULL
a	NULL
region	NULL
around	NULL
-175	NULL
bp	NULL
(	NULL
FP1	NULL
)	NULL
were	NULL
footprinted	NULL
.	NULL

three	NULL
major	NULL
bands	NULL
(	NULL
1	NULL
,	NULL
2	NULL
and	NULL
4	NULL
)	NULL
and	NULL
a	NULL
band	NULL
of	NULL
lesser	NULL
intensity	NULL
(	NULL
band	NULL
3	NULL
)	NULL
corresponding	NULL
to	NULL
various	NULL
DNA-protein	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
the	NULL
faint	NULL
band	NULL
between	NULL
bands	NULL
3	NULL
and	NULL
4	NULL
was	NULL
not	NULL
consistent	NULL
and	NULL
appeared	NULL
to	NULL
be	NULL
non-specific	NULL
.	NULL

Competition	NULL
with	NULL
cold	NULL
probe	NULL
(	NULL
ER	NULL
)	NULL
was	NULL
able	NULL
to	NULL
effectively	NULL
displace	NULL
bands	NULL
1-4	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lanes	NULL
1-4	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
these	NULL
bands	NULL
represented	NULL
specific	NULL
binding	NULL
of	NULL
OCIM1	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
hEpoR	NULL
promoter	NULL
.	NULL

Bands	NULL
representing	NULL
binding	NULL
to	NULL
the	NULL
Sp1	NULL
consensus	NULL
sequence	NULL
were	NULL
identified	NULL
using	NULL
an	NULL
Spl	NULL
(	NULL
SP1	NULL
)	NULL
DNA	NULL
competitor	NULL
unrelated	NULL
to	NULL
hEpoR	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lanes	NULL
5-9	NULL
)	NULL
.	NULL

This	NULL
competitor	NULL
markedly	NULL
reduced	NULL
the	NULL
intensities	NULL
of	NULL
band	NULL
1	NULL
,	NULL
3	NULL
and	NULL
4	NULL
.	NULL

A	NULL
20	NULL
bp	NULL
Sp1	NULL
competitor	NULL
from	NULL
hEpoR	NULL
(	NULL
SP1ER	NULL
)	NULL
also	NULL
reduced	NULL
the	NULL
intensity	NULL
of	NULL
bands	NULL
1	NULL
,	NULL
3	NULL
and	NULL
4	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Antibodies	NULL
specific	NULL
to	NULL
Spl	NULL
protein	NULL
(	NULL
anti-SP1	NULL
;	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
Inc.	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
incubated	NULL
with	NULL
the	NULL
reaction	NULL
mixture	NULL
resulted	NULL
in	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
intensity	NULL
of	NULL
band	NULL
1	NULL
and	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
new	NULL
band	NULL
of	NULL
high	NULL
molecular	NULL
weight	NULL
(	NULL
representing	NULL
a	NULL
new	NULL
complex	NULL
consisting	NULL
of	NULL
antibody	NULL
,	NULL
Spl	NULL
protein	NULL
and	NULL
probe	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
band	NULL
2	NULL
represents	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
GATA-1	NULL
binding	NULL
motif	NULL
,	NULL
that	NULL
band	NULL
1	NULL
represents	NULL
ER	NULL
SP1	NULL
Anti-SP1	NULL
mum	NULL
``	NULL
me-	NULL
~A	NULL
_	NULL
mme	NULL
}	NULL
Po	NULL
O2	NULL
3	NULL
40	NULL
50	NULL
60	NULL
7	NULL
8	NULL
9	NULL
dd	NULL
df	NULL
12	NULL
13	NULL
14	NULL
iaa	NULL
mall	NULL
o	NULL
B	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1995	NULL
,	NULL
Vol	NULL
.	NULL

23	NULL
,	NULL
No	NULL
.	NULL

15	NULL
3045	NULL
ER	NULL
SP1	NULL
Anti-SP1	NULL
muse	NULL
]	NULL
=-	NULL
]	NULL
Po	NULL
O2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
-	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
tit	NULL
g	NULL
ﬂ	NULL
g	NULL
®	NULL
is	NULL
bo	NULL
bo	NULL
t	NULL
Figure	NULL
3	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
assay	NULL
of	NULL
the	NULL
hEpoR	NULL
promoter	NULL
and	NULL
Sp1	NULL
antibody	NULL
.	NULL

(	NULL
A	NULL
)	NULL
A	NULL
double-stranded	NULL
hEpoR	NULL
fragment	NULL
extending	NULL
from	NULL
the	NULL
cap	NULL
site	NULL
to	NULL
-63	NULL
bp	NULL
5	NULL
``	NULL
was	NULL
and	NULL
incubated	NULL
with	NULL
OCIM1	NULL
nuclear	NULL
extract	NULL
or	NULL
no	NULL
nuclear	NULL
extract	NULL
(	NULL
P	NULL
)	NULL
as	NULL
indicated	NULL
.	NULL

Lane	NULL
1	NULL
contains	NULL
no	NULL
specific	NULL
DNA	NULL
competitor	NULL
.	NULL

Lanes	NULL
2-4	NULL
contain	NULL
cold	NULL
probe	NULL
(	NULL
10	NULL
,	NULL
30	NULL
and	NULL
100	NULL
%	NULL
)	NULL
.	NULL

Lanes	NULL
5-9	NULL
contain	NULL
Spi-specific	NULL
DNA	NULL
competitor	NULL
(	NULL
10	NULL
,	NULL
25	NULL
,	NULL
50	NULL
,	NULL
75	NULL
and	NULL
100	NULL
%	NULL
)	NULL
.	NULL

Lanes	NULL
10-14	NULL
contain	NULL
anti-Sp1	NULL
antibody	NULL
(	NULL
10	NULL
,	NULL
25	NULL
,	NULL
50	NULL
,	NULL
80	NULL
and	NULL
100	NULL
ng	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Probe	NULL
was	NULL
incubated	NULL
with	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
or	NULL
no	NULL
nuclear	NULL
extract	NULL
(	NULL
P	NULL
)	NULL
as	NULL
indicated	NULL
.	NULL

Lane	NULL
1	NULL
contains	NULL
no	NULL
specific	NULL
DNA	NULL
competitor	NULL
.	NULL

Lanes	NULL
2-4	NULL
contain	NULL
cold	NULL
probe	NULL
(	NULL
10	NULL
,	NULL
30	NULL
and	NULL
100	NULL
%	NULL
)	NULL
.	NULL

Lanes	NULL
5-8	NULL
contain	NULL
Sp	NULL
!	NULL

-specific	NULL
DNA	NULL
competitor	NULL
(	NULL
1	NULL
,	NULL
10	NULL
,	NULL
100	NULL
and	NULL
500	NULL
%	NULL
)	NULL
.	NULL

Lanes	NULL
9-15	NULL
contain	NULL
anti-Spl	NULL
antibody	NULL
(	NULL
1	NULL
,	NULL
10	NULL
,	NULL
100	NULL
and	NULL
300	NULL
ng	NULL
and	NULL
1	NULL
and	NULL
3	NULL
ug	NULL
)	NULL
.	NULL

binding	NULL
of	NULL
Sp1	NULL
protein	NULL
and	NULL
that	NULL
bands	NULL
3	NULL
and	NULL
4	NULL
represent	NULL
other	NULL
non-Spl	NULL
nuclear	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
CCGCCC	NULL
Sp1	NULL
binding	NULL
motif	NULL
.	NULL

Incubation	NULL
of	NULL
probe	NULL
with	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
resulted	NULL
in	NULL
a	NULL
gel	NULL
mobility	NULL
shift	NULL
pattern	NULL
consisting	NULL
of	NULL
two	NULL
major	NULL
bands	NULL
(	NULL
1	NULL
'	NULL
and	NULL
a	NULL
broad	NULL
band	NULL
,	NULL
4	NULL
``	NULL
)	NULL
and	NULL
two	NULL
bands	NULL
(	NULL
2	NULL
'	NULL
and	NULL
3	NULL
``	NULL
)	NULL
of	NULL
lesser	NULL
intensity	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
which	NULL
could	NULL
be	NULL
competed	NULL
with	NULL
ER	NULL
.	NULL

Bands	NULL
1	NULL
'	NULL
,	NULL
3	NULL
'	NULL
and	NULL
4	NULL
``	NULL
from	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
behaved	NULL
similarly	NULL
to	NULL
bands	NULL
1	NULL
,	NULL
3	NULL
and	NULL
4	NULL
from	NULL
OCIM	NULL
!	NULL

1	NULL
nuclear	NULL
extract	NULL
when	NULL
incubated	NULL
with	NULL
SP1	NULL
and	NULL
the	NULL
Spl	NULL
-specific	NULL
antibody	NULL
anti-SP1	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
,	NULL
as	NULL
with	NULL
OCIM1	NULL
nuclear	NULL
extracts	NULL
,	NULL
band	NULL
1	NULL
'	NULL
represents	NULL
binding	NULL
of	NULL
Spl	NULL
protein	NULL
and	NULL
bands	NULL
3	NULL
'	NULL
and	NULL
4	NULL
'	NULL
represent	NULL
other	NULL
non-Spl	NULL
nuclear	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
Spl	NULL
binding	NULL
motif	NULL
.	NULL

For	NULL
OCIM1	NULL
nuclear	NULL
extract	NULL
a	NULL
GATA-1	NULL
DNA	NULL
competitor	NULL
from	NULL
the	NULL
g-globin	NULL
gene	NULL
promoter	NULL
(	NULL
GATA-1¢	NULL
)	NULL
was	NULL
able	NULL
to	NULL
reduce	NULL
the	NULL
intensity	NULL
of	NULL
band	NULL
2	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lanes	NULL
1-3	NULL
)	NULL
.	NULL

A	NULL
synthetic	NULL
20	NULL
bp	NULL
DNA	NULL
fragment	NULL
centered	NULL
at	NULL
the	NULL
hEpoR	NULL
GATA-1	NULL
binding	NULL
motif	NULL
(	NULL
GATA-1ER	NULL
)	NULL
was	NULL
also	NULL
able	NULL
to	NULL
compete	NULL
for	NULL
binding	NULL
of	NULL
protein	NULL
represented	NULL
in	NULL
band	NULL
2	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lanes	NULL
4-9	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
DNA-protein	NULL
complex	NULL
represented	NULL
by	NULL
band	NULL
2	NULL
corresponds	NULL
to	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
GATA-1	NULL
binding	NULL
motif	NULL
.	NULL

Incubation	NULL
with	NULL
anti-GATA-1	NULL
antibody	NULL
(	NULL
N6	NULL
)	NULL
specific	NULL
for	NULL
GATA-1	NULL
protein	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
Inc.	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
(	NULL
18	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
relative	NULL
intensity	NULL
of	NULL
band	NULL
2	NULL
with	NULL
a	NULL
marked	NULL
increase	NULL
in	NULL
intensity	NULL
of	NULL
bands	NULL
1	NULL
,	NULL
3	NULL
and	NULL
4	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
anti-GATA-1	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
competition	NULL
pattern	NULL
observed	NULL
with	NULL
the	NULL
GATA-1ER	NULL
competitor	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
no	NULL
high	NULL
molecular	NULL
weight	NULL
band	NULL
appeared	NULL
,	NULL
indicating	NULL
the	NULL
lack	NULL
of	NULL
formation	NULL
of	NULL
an	NULL
antibody-GATA-1	NULL
protein-DNA	NULL
probe	NULL
complex	NULL
.	NULL

Incubation	NULL
with	NULL
antibodies	NULL
specific	NULL
for	NULL
TFIID	NULL
(	NULL
anti-	NULL
TFIID	NULL
;	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
Inc.	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
or	NULL
with	NULL
a	NULL
synthetic	NULL
DNA	NULL
fragment	NULL
containing	NULL
a	NULL
TFIID	NULL
binding	NULL
motif	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
gel	NULL
mobility	NULL
shift	NULL
pattern	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

HeLa	NULL
cells	NULL
,	NULL
although	NULL
they	NULL
do	NULL
not	NULL
express	NULL
GATA-1	NULL
protein	NULL
,	NULL
do	NULL
express	NULL
GATA-2	NULL
protein	NULL
,	NULL
which	NULL
has	NULL
a	NULL
DNA	NULL
binding	NULL
motif	NULL
similar	NULL
to	NULL
GATA-1	NULL
protein	NULL
(	NULL
19,20	NULL
)	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
band	NULL
2	NULL
``	NULL
is	NULL
low	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
)	NULL
.	NULL

However	NULL
,	NULL
incubation	NULL
with	NULL
the	NULL
specific	NULL
DNA	NULL
competitor	NULL
GATA-1ER	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
GATA-1	NULL
binding	NULL
motif	NULL
,	NULL
further	NULL
decreases	NULL
the	NULL
intensity	NULL
of	NULL
band	NULL
2	NULL
``	NULL
,	NULL
with	NULL
a	NULL
marked	NULL
increase	NULL
in	NULL
the	NULL
intensity	NULL
of	NULL
bands	NULL
1	NULL
'	NULL
and	NULL
3	NULL
'	NULL
,	NULL
a	NULL
pattern	NULL
similar	NULL
to	NULL
that	NULL
obtained	NULL
with	NULL
OCIM1	NULL
nuclear	NULL
extracts	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
band	NULL
2	NULL
``	NULL
may	NULL
represent	NULL
binding	NULL
of	NULL
protein	NULL
from	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
,	NULL
possibly	NULL
GATA-2	NULL
,	NULL
to	NULL
the	NULL
GATA-1	NULL
motif	NULL
,	NULL
but	NULL
at	NULL
a	NULL
much	NULL
lower	NULL
level	NULL
than	NULL
that	NULL
observed	NULL
for	NULL
OCIM1	NULL
nuclear	NULL
extract	NULL
.	NULL

Functional	NULL
studies	NULL
of	NULL
the	NULL
hEpoR	NULL
promoter	NULL
Truncated	NULL
deletions	NULL
were	NULL
constructed	NULL
around	NULL
the	NULL
DNase	NULL
I	NULL
footprinted	NULL
regions	NULL
of	NULL
the	NULL
hEpoR	NULL
promoter	NULL
beginning	NULL
5¢	NULL
from	NULL
-194	NULL
(	NULL
A194	NULL
)	NULL
,	NULL
-116	NULL
(	NULL
A116	NULL
)	NULL
,	NULL
-68	NULL
(	NULL
A68	NULL
)	NULL
,	NULL
-29	NULL
(	NULL
A29	NULL
)	NULL
and	NULL
+3	NULL
bp	NULL
(	NULL
A+3	NULL
)	NULL
relative	NULL
to	NULL
the	NULL
cap	NULL
site	NULL
and	NULL
extending	NULL
3	NULL
'	NULL
to	NULL
+123	NULL
bp	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
A194	NULL
,	NULL
A116	NULL
and	NULL
A68	NULL
constructs	NULL
were	NULL
at	NULL
least	NULL
6-fold	NULL
more	NULL
active	NULL
in	NULL
OCIM1	NULL
cells	NULL
than	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Co-transfection	NULL
with	NULL
the	NULL
GATA-1	NULL
expression	NULL
vector	NULL
in	NULL
HeLa	NULL
cells	NULL
also	NULL
resulted	NULL
in	NULL
transactivation	NULL
of	NULL
the	NULL
promoter	NULL
activity	NULL
of	NULL
A194	NULL
,	NULL
A116	NULL
and	NULL
A68	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
OCIM1	NULL
cells	NULL
the	NULL
region	NULL
between	NULL
-194	NULL
and	NULL
-116	NULL
bp	NULL
containing	NULL
the	NULL
DNase	NULL
footprinted	NULL
region	NULL
around	NULL
-175	NULL
bp	NULL
provided	NULL
some	NULL
negative	NULL
regulatory	NULL
activity	NULL
,	NULL
as	NULL
deletion	NULL
of	NULL
this	NULL
region	NULL
resulted	NULL
in	NULL
a	NULL
>	NULL
2-fold	NULL
increase	NULL
(	NULL
P	NULL
=	NULL
0.002	NULL
)	NULL
in	NULL
transcription	NULL
activity	NULL
(	NULL
consistent	NULL
with	NULL
the	NULL
data	NULL
in	NULL
3046	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1995	NULL
,	NULL
Vol	NULL
.	NULL

23	NULL
,	NULL
No	NULL
.	NULL

15	NULL
Figure	NULL
4	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
assay	NULL
of	NULL
the	NULL
hEpoR	NULL
promoter	NULL
region	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
hEpoR	NULL
promoter	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
OCIMI1	NULL
nuclear	NULL
extract	NULL
.	NULL

Lanes	NULL
1	NULL
and	NULL
4	NULL
contain	NULL
no	NULL
specific	NULL
DNA	NULL
competitor	NULL
.	NULL

Lanes	NULL
2	NULL
and	NULL
3	NULL
contain	NULL
GATA-1	NULL
DNA	NULL
competitor	NULL
from	NULL
the	NULL
E-globin	NULL
gene	NULL
sequence	NULL
(	NULL
165	NULL
and	NULL
400	NULL
%	NULL
)	NULL
.	NULL

Lanes	NULL
5-9	NULL
contain	NULL
a	NULL
20	NULL
bp	NULL
GATA-1	NULL
DNA	NULL
competitor	NULL
from	NULL
hEpoR	NULL
(	NULL
20	NULL
,	NULL
40	NULL
,	NULL
60	NULL
,	NULL
80	NULL
and	NULL
100	NULL
%	NULL
)	NULL
.	NULL

Lanes	NULL
10	NULL
and	NULL
11	NULL
contain	NULL
a	NULL
20	NULL
bp	NULL
Spl	NULL
DNA	NULL
competitor	NULL
from	NULL
hEpoR	NULL
(	NULL
10	NULL
and	NULL
20	NULL
%	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
hEpoR	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
OCIM1	NULL
nuclear	NULL
extract	NULL
.	NULL

Lanes	NULL
1-5	NULL
contain	NULL
anti-GATA-1	NULL
antibody	NULL
(	NULL
1	NULL
,	NULL
10	NULL
,	NULL
100	NULL
and	NULL
300	NULL
ng	NULL
and	NULL
1	NULL
ug	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
hEpoR	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
OCIM	NULL
I1	NULL
nuclear	NULL
extract	NULL
.	NULL

Lanes	NULL
2-6	NULL
contain	NULL
anti-	NULL
TFIID	NULL
antibody	NULL
(	NULL
10	NULL
,	NULL
100	NULL
and	NULL
300	NULL
ng	NULL
and	NULL
1	NULL
and	NULL
3	NULL
jug	NULL
)	NULL
.	NULL

Lanes	NULL
7-9	NULL
contain	NULL
TFIID-specific	NULL
DNA	NULL
competitor	NULL
(	NULL
1	NULL
,	NULL
10	NULL
and	NULL
100	NULL
%	NULL
)	NULL
.	NULL

(	NULL
D	NULL
)	NULL
The	NULL
hEpoR	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
.	NULL

Lane	NULL
1	NULL
contains	NULL
no	NULL
specific	NULL
DNA	NULL
competitor	NULL
.	NULL

Lanes	NULL
2-6	NULL
contain	NULL
a	NULL
20	NULL
bp	NULL
GATA-1-specific	NULL
DNA	NULL
competitor	NULL
from	NULL
hEpoR	NULL
(	NULL
20	NULL
,	NULL
40	NULL
,	NULL
60	NULL
,	NULL
80	NULL
and	NULL
100	NULL
%	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
region	NULL
between	NULL
-68	NULL
and	NULL
-116	NULL
bp	NULL
containing	NULL
the	NULL
AP2	NULL
site	NULL
provided	NULL
positive	NULL
regulatory	NULL
activity	NULL
and	NULL
deletion	NULL
of	NULL
this	NULL
region	NULL
resulted	NULL
in	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
transcription	NULL
activity	NULL
of	NULL
A68	NULL
compared	NULL
with	NULL
A116	NULL
(	NULL
P	NULL
=	NULL
0.001	NULL
)	NULL
.	NULL

The	NULL
A29	NULL
hEpoR	NULL
construct	NULL
represents	NULL
deletion	NULL
of	NULL
the	NULL
GATA-1	NULL
binding	NULL
motif	NULL
and	NULL
5	NULL
'	NULL
sequences	NULL
.	NULL

We	NULL
have	NULL
also	NULL
constructed	NULL
two	NULL
mutations	NULL
of	NULL
the	NULL
GATA-1	NULL
binding	NULL
motif	NULL
within	NULL
the	NULL
A194	NULL
construct	NULL
using	NULL
site-directed	NULL
mutagenesis	NULL
to	NULL
replace	NULL
the	NULL
GATA-1	NULL
binding	NULL
motif	NULL
with	NULL
CTGCAG	NULL
for	NULL
AGATA-a	NULL
and	NULL
CTCGAG	NULL
for	NULL
AGATA-b	NULL
.	NULL

When	NULL
assayed	NULL
in	NULL
OCIM1	NULL
cells	NULL
deletion	NULL
or	NULL
mutation	NULL
of	NULL
the	NULL
GATA-1	NULL
binding	NULL
site	NULL
at	NULL
-45	NULL
bp	NULL
reduced	NULL
transcription	NULL
activity	NULL
to	NULL
50-70	NULL
%	NULL
of	NULL
the	NULL
native	NULL
construct	NULL
(	NULL
Figs	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
deletion	NULL
or	NULL
mutation	NULL
of	NULL
the	NULL
GATA-1	NULL
binding	NULL
site	NULL
in	NULL
HeLa	NULL
cells	NULL
did	NULL
not	NULL
decrease	NULL
transcription	NULL
activity	NULL
.	NULL

While	NULL
increasing	NULL
GATA-1	NULL
levels	NULL
in	NULL
OCIM1	NULL
cells	NULL
was	NULL
not	NULL
able	NULL
to	NULL
further	NULL
increase	NULL
transcription	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
,	NULL
the	NULL
reduction	NULL
in	NULL
transcription	NULL
activity	NULL
observed	NULL
by	NULL
mutation	NULL
or	NULL
deletion	NULL
of	NULL
the	NULL
GATA-1	NULL
binding	NULL
site	NULL
demonstrates	NULL
its	NULL
importance	NULL
in	NULL
transcription	NULL
activity	NULL
in	NULL
OCIM	NULL
!	NULL

1	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
mutation	NULL
or	NULL
deletion	NULL
of	NULL
the	NULL
GATA-1	NULL
binding	NULL
site	NULL
on	NULL
transcription	NULL
activity	NULL
in	NULL
HeLa	NULL
cells	NULL
suggests	NULL
that	NULL
although	NULL
GATA-2	NULL
and	NULL
GATA-1	NULL
share	NULL
similar	NULL
DNA	NULL
binding	NULL
sites	NULL
,	NULL
GATA-2	NULL
in	NULL
HeLa	NULL
cells	NULL
does	NULL
not	NULL
act	NULL
to	NULL
increase	NULL
hEpoR	NULL
promoter	NULL
activity	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
dependence	NULL
of	NULL
transcription	NULL
activation	NULL
on	NULL
the	NULL
Spl	NULL
binding	NULL
site	NULL
,	NULL
we	NULL
used	NULL
site-directed	NULL
mutagenesis	NULL
to	NULL
alter	NULL
the	NULL
Spl	NULL
binding	NULL
motif	NULL
in	NULL
the	NULL
A194	NULL
construct	NULL
,	NULL
resulting	NULL
in	NULL
plasmid	NULL
ASp1	NULL
.	NULL

When	NULL
transfected	NULL
into	NULL
OCIM1	NULL
cells	NULL
promoter	NULL
activity	NULL
was	NULL
markedly	NULL
reduced	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
double	NULL
mutation	NULL
of	NULL
both	NULL
Spl	NULL
and	NULL
GATA-1	NULL
binding	NULL
sites	NULL
in	NULL
plasmid	NULL
ASpIAGATA1	NULL
further	NULL
reduced	NULL
promoter	NULL
activity	NULL
in	NULL
OCIMI1	NULL
cells	NULL
to	NULL
that	NULL
observed	NULL
for	NULL
the	NULL
control	NULL
construct	NULL
containing	NULL
no	NULL
promoter	NULL
.	NULL

Promoter	NULL
activities	NULL
of	NULL
ASpl	NULL
and	NULL
ASpIlAGATAl	NULL
were	NULL
also	NULL
decreased	NULL
compared	NULL
with	NULL
the	NULL
unmutated	NULL
hEpoR	NULL
promoter	NULL
when	NULL
these	NULL
constructs	NULL
were	NULL
transfected	NULL
into	NULL
HeLa	NULL
cells	NULL
.	NULL

Although	NULL
mutation	NULL
of	NULL
the	NULL
Spl	NULL
site	NULL
(	NULL
ASpl	NULL
)	NULL
resulted	NULL
in	NULL
low	NULL
transcription	NULL
activity	NULL
of	NULL
the	NULL
hEpoR	NULL
promoter	NULL
,	NULL
this	NULL
construct	NULL
was	NULL
still	NULL
responsive	NULL
to	NULL
transactivation	NULL
by	NULL
GATA-1	NULL
.	NULL

Co-transfection	NULL
of	NULL
ASpl	NULL
with	NULL
the	NULL
GATA-1	NULL
expression	NULL
vector	NULL
resulted	NULL
in	NULL
a	NULL
6-fold	NULL
increase	NULL
in	NULL
transcription	NULL
activity	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
transactivation	NULL
by	NULL
GATA-1	NULL
was	NULL
also	NULL
observed	NULL
when	NULL
ASpl	NULL
was	NULL
co-transfected	NULL
into	NULL
OCIM1	NULL
cells	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
transactivation	NULL
by	NULL
GATA-1	NULL
,	NULL
not	NULL
observed	NULL
when	NULL
hEpoR	NULL
promoter	NULL
activity	NULL
is	NULL
high	NULL
,	NULL
can	NULL
be	NULL
restored	NULL
when	NULL
promoter	NULL
activity	NULL
is	NULL
markedly	NULL
reduced	NULL
and	NULL
that	NULL
a	NULL
high	NULL
level	NULL
of	NULL
hEpoR	NULL
transcription	NULL
activation	NULL
depends	NULL
on	NULL
coordination	NULL
of	NULL
both	NULL
Sp1	NULL
(	NULL
or	NULL
Spl-like	NULL
)	NULL
and	NULL
GATA-1	NULL
transcription	NULL
factors	NULL
with	NULL
other	NULL
cell-specific	NULL
factors	NULL
.	NULL

DISCUSSION	NULL
We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
a	NULL
genomic	NULL
fragment	NULL
containing	NULL
700	NULL
bp	NULL
of	NULL
5¢	NULL
sequence	NULL
flanking	NULL
the	NULL
hEpoR	NULL
coding	NULL
region	NULL
was	NULL
functional	NULL
in	NULL
an	NULL
in	NULL
vitro	NULL
transcription	NULL
system	NULL
based	NULL
on	NULL
nuclear	NULL
extracts	NULL
from	NULL
human	NULL
erythroid	NULL
cells	NULL
and	NULL
provided	NULL
a	NULL
RNA	NULL
transcript	NULL
correctly	NULL
initiated	NULL
at	NULL
1	NULL
34	NULL
bp	NULL
5	NULL
``	NULL
of	NULL
the	NULL
translation	NULL
start	NULL
site	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Recently	NULL
we	NULL
reported	NULL
that	NULL
a	NULL
15	NULL
kb	NULL
hEpoR	NULL
transgene	NULL
with	NULL
2	NULL
kb	NULL
of	NULL
5	NULL
'	NULL
flanking	NULL
sequence	NULL
was	NULL
able	NULL
to	NULL
direct	NULL
hematopoiesis-specific	NULL
expression	NULL
(	NULL
with	NULL
low	NULL
level	NULL
brain	NULL
expression	NULL
)	NULL
in	NULL
transgenic	NULL
mice	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
provide	NULL
an	NULL
analysis	NULL
of	NULL
the	NULL
5¢	NULL
region	NULL
of	NULL
the	NULL
hEpoR	NULL
gene	NULL
with	NULL
emphasis	NULL
on	NULL
the	NULL
proximal	NULL
promoter	NULL
.	NULL

All	NULL
the	NULL
constructs	NULL
containing	NULL
the	NULL
hEpoR	NULL
5	NULL
flanking	NULL
region	NULL
extending	NULL
from	NULL
-150	NULL
bp	NULL
or	NULL
more	NULL
5	NULL
'	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
,	NULL
which	NULL
contain	NULL
the	NULL
binding	NULL
sites	NULL
for	NULL
transcription	NULL
factors	NULL
Spl	NULL
and	NULL
the	NULL
erythroid-specific	NULL
A	NULL
,	NULL
Footprint	NULL
:	NULL
|	NULL
ca	NULL
ma	NULL
ua	NULL
-_	NULL
aa	NULL
_	NULL
Cap	NULL
Site	NULL
»	NULL
FP1	NULL
-2	NULL
GATA	NULL
i	NULL
(	NULL
FP1	NULL
)	NULL
_	NULL
AP2	NULL
GATA	NULL
smr	NULL
’	NULL
pal-mdrome	NULL
Es-T	NULL
T	NULL
I	NULL
T	NULL
I	NULL
-200	NULL
-100	NULL
+1	NULL
100	NULL
~194	NULL
A194	NULL
116	NULL
M16	NULL
A68	NULL
A29	NULL
A+3	NULL
B	NULL
o	NULL
*	NULL
t	NULL
>	NULL
®	NULL
£	NULL
.s	NULL
ka	NULL
€	NULL
0	NULL
®	NULL
§	NULL
@	NULL
o	NULL
3	NULL
-J	NULL
0	NULL
A194	NULL
A116	NULL
A68	NULL
A29	NULL
ars	NULL
C	NULL
&	NULL
t	NULL
C.	NULL
$	NULL
39	NULL
©	NULL
~	NULL
HeLa	NULL
=	NULL
>	NULL
0.1	NULL
S3	NULL
s	NULL
0	NULL
A194	NULL
A116	NULL
A68	NULL
-	NULL
a29	NULL
A+3	NULL
C	NULL
Figure	NULL
5	NULL
.	NULL

Transfection	NULL
assay	NULL
of	NULL
the	NULL
hEpoR	NULL
promoter	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Human	NULL
EpoR	NULL
reporter	NULL
gene	NULL
deletion	NULL
mutants	NULL
were	NULL
constructed	NULL
extending	NULL
to	NULL
-194	NULL
(	NULL
A194	NULL
)	NULL
,	NULL
-116	NULL
(	NULL
A116	NULL
)	NULL
,	NULL
-68	NULL
(	NULL
A68	NULL
)	NULL
,	NULL
-29	NULL
(	NULL
A29	NULL
)	NULL
and	NULL
+3	NULL
bp	NULL
(	NULL
A+3	NULL
)	NULL
relative	NULL
to	NULL
the	NULL
cap	NULL
site	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
hEpoR	NULL
constructs	NULL
were	NULL
transfected	NULL
into	NULL
OCIM1	NULL
cells	NULL
.	NULL

Data	NULL
normalized	NULL
to	NULL
SV40	NULL
promoter	NULL
luciferase	NULL
activity	NULL
are	NULL
plotted	NULL
.	NULL

The	NULL
control	NULL
construct	NULL
(	NULL
C	NULL
)	NULL
contains	NULL
no	NULL
promoter	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Data	NULL
obtained	NULL
for	NULL
the	NULL
hEpoR	NULL
constructs	NULL
assayed	NULL
in	NULL
HeLa	NULL
cells	NULL
are	NULL
plotted	NULL
.	NULL

GATA-1	NULL
,	NULL
were	NULL
transcriptionally	NULL
active	NULL
in	NULL
erythroid	NULL
OCIM1	NULL
and	NULL
K562	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
CACCC	NULL
motif	NULL
,	NULL
which	NULL
has	NULL
been	NULL
associated	NULL
with	NULL
transcription	NULL
activity	NULL
of	NULL
globin	NULL
and	NULL
other	NULL
erythroid	NULL
promoters	NULL
,	NULL
is	NULL
usually	NULL
located	NULL
within	NULL
or	NULL
in	NULL
close	NULL
proximity	NULL
to	NULL
the	NULL
promoter	NULL
(	NULL
20,21	NULL
)	NULL
.	NULL

For	NULL
the	NULL
hEpoR	NULL
gene	NULL
five	NULL
CACCC	NULL
motifs	NULL
are	NULL
located	NULL
in	NULL
more	NULL
distal	NULL
5°	NULL
regions	NULL
(	NULL
3	NULL
)	NULL
and	NULL
deletion	NULL
of	NULL
these	NULL
motifs	NULL
had	NULL
a	NULL
<	NULL
2-fold	NULL
effect	NULL
on	NULL
promoter	NULL
activity	NULL
.	NULL

The	NULL
murine	NULL
EpoR	NULL
gene	NULL
contains	NULL
three	NULL
CACCC	NULL
motifs	NULL
localized	NULL
within	NULL
400	NULL
bp	NULL
5¢	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
(	NULL
22	NULL
)	NULL
,	NULL
with	NULL
one	NULL
at	NULL
-261	NULL
bp	NULL
which	NULL
contributes	NULL
significantly	NULL
to	NULL
murine	NULL
EpoR	NULL
promoter	NULL
activity	NULL
(	NULL
23	NULL
)	NULL
.	NULL

The	NULL
region	NULL
between	NULL
-1778	NULL
and	NULL
-937	NULL
bp	NULL
in	NULL
the	NULL
hEpoR	NULL
gene	NULL
includes	NULL
homology	NULL
to	NULL
Alu	NULL
repetitive	NULL
sequences	NULL
and	NULL
is	NULL
associated	NULL
with	NULL
some	NULL
positive	NULL
control	NULL
.	NULL

The	NULL
murine	NULL
EpoR	NULL
gene	NULL
contains	NULL
a	NULL
rodent-specific	NULL
repetitive	NULL
sequence	NULL
between	NULL
-1703	NULL
and	NULL
-1063	NULL
bp	NULL
with	NULL
negative	NULL
regulatory	NULL
activity	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Additional	NULL
regulatory	NULL
motifs	NULL
found	NULL
in	NULL
the	NULL
hEpoR	NULL
promoter	NULL
include	NULL
a	NULL
region	NULL
with	NULL
an	NULL
AP2	NULL
binding	NULL
site	NULL
located	NULL
at	NULL
-101	NULL
bp	NULL
in	NULL
the	NULL
hEpoR	NULL
promoter	NULL
(	NULL
Fig.2	NULL
)	NULL
with	NULL
some	NULL
positive	NULL
regulatory	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
and	NULL
the	NULL
region	NULL
between	NULL
-116	NULL
and	NULL
-194	NULL
bp	NULL
containing	NULL
a	NULL
DNase	NULL
I	NULL
footprinted	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
associated	NULL
with	NULL
negative	NULL
regulatory	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

These	NULL
differences	NULL
between	NULL
the	NULL
human	NULL
and	NULL
murine	NULL
regulatory	NULL
elements	NULL
illustrate	NULL
that	NULL
the	NULL
human	NULL
and	NULL
murine	NULL
EpoR	NULL
genes	NULL
are	NULL
not	NULL
under	NULL
identical	NULL
regulatory	NULL
control	NULL
.	NULL

In	NULL
erythroid	NULL
cells	NULL
much	NULL
of	NULL
the	NULL
hEpoR	NULL
transcription	NULL
activity	NULL
is	NULL
contained	NULL
within	NULL
the	NULL
150	NULL
bp	NULL
fragment	NULL
5	NULL
'	NULL
of	NULL
the	NULL
cap	NULL
site	NULL
with	NULL
activity	NULL
equal	NULL
to	NULL
or	NULL
greater	NULL
than	NULL
the	NULL
longest	NULL
A1778	NULL
construct	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
relative	NULL
activity	NULL
of	NULL
the	NULL
hEpoR	NULL
constructs	NULL
mirrored	NULL
the	NULL
high	NULL
and	NULL
low	NULL
levels	NULL
of	NULL
constitutive	NULL
hEpoR	NULL
expression	NULL
in	NULL
OCIM1	NULL
and	NULL
K562	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
non-erythroid	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1995	NULL
,	NULL
Vol	NULL
.	NULL

23	NULL
,	NULL
No	NULL
.	NULL

15	NULL
3047	NULL
by	NULL
I	NULL
OCIM1	NULL
_	NULL
7	NULL
Fold	NULL
increase	NULL
>	NULL
GATA1	NULL
L-__+J	NULL
AGATA-a	NULL
AGATA-b	NULL
L-__+j	NULL
ASp1AGATA	NULL
C	NULL
A194	NULL
ASp1	NULL
HeLa	NULL
Fold	NULL
increase	NULL
GATA1	NULL
L-	NULL
_	NULL
tJ	NULL
-	NULL
L=_tJ	NULL
-	NULL
_	NULL
tj	NULL
A194	NULL
_	NULL
AGATA-a	NULL
AGATA-b	NULL
ASp1	NULL
ASp1AGATA	NULL
C	NULL
Figure	NULL
6	NULL
.	NULL

Transfection	NULL
assay	NULL
with	NULL
mutated	NULL
hEpoR	NULL
promoters	NULL
.	NULL

The	NULL
hEpoR	NULL
construct	NULL
A194	NULL
was	NULL
mutated	NULL
at	NULL
the	NULL
GATA-1	NULL
binding	NULL
site	NULL
(	NULL
AGATA-a	NULL
and	NULL
AGATA-b	NULL
)	NULL
,	NULL
at	NULL
the	NULL
Sp1	NULL
binding	NULL
site	NULL
(	NULL
ASP1	NULL
)	NULL
and	NULL
at	NULL
both	NULL
the	NULL
GATA-1	NULL
and	NULL
Sp1	NULL
binding	NULL
sites	NULL
(	NULL
ASPIAGATA	NULL
)	NULL
.	NULL

The	NULL
control	NULL
construct	NULL
(	NULL
C	NULL
)	NULL
contains	NULL
no	NULL
promoter	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Constructs	NULL
were	NULL
assayed	NULL
in	NULL
OCIMI1	NULL
cells	NULL
and	NULL
data	NULL
normalized	NULL
to	NULL
A194	NULL
activity	NULL
.	NULL

Also	NULL
indicated	NULL
are	NULL
co-transfections	NULL
with	NULL
RSV-GATA-1	NULL
(	NULL
+	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Constructs	NULL
were	NULL
assayed	NULL
in	NULL
HeLa	NULL
cells	NULL
and	NULL
data	NULL
normalized	NULL
to	NULL
A194	NULL
(	NULL
Native	NULL
)	NULL
activity	NULL
.	NULL

HeLa	NULL
cells	NULL
the	NULL
hEpoR	NULL
promoter	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
length	NULL
of	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
and	NULL
the	NULL
activity	NULL
of	NULL
A150	NULL
is	NULL
>	NULL
5-fold	NULL
lower	NULL
than	NULL
the	NULL
activity	NULL
of	NULL
A1778	NULL
.	NULL

Mutation	NULL
or	NULL
deletion	NULL
of	NULL
the	NULL
GATA-1	NULL
site	NULL
markedly	NULL
reduced	NULL
transcription	NULL
activity	NULL
in	NULL
OCIM1	NULL
cells	NULL
,	NULL
but	NULL
exhibited	NULL
no	NULL
reduction	NULL
of	NULL
transcription	NULL
activity	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

In	NULL
the	NULL
human	NULL
EpoR	NULL
gene	NULL
only	NULL
one	NULL
perfect	NULL
GATA-1	NULL
binding	NULL
consensus	NULL
sequence	NULL
at	NULL
-45	NULL
bp	NULL
is	NULL
found	NULL
in	NULL
the	NULL
5¢	NULL
flanking	NULL
region	NULL
(	NULL
3	NULL
)	NULL
.	NULL

The	NULL
variation	NULL
in	NULL
GATA-1	NULL
binding	NULL
motifs	NULL
(	NULL
19,20	NULL
)	NULL
suggests	NULL
that	NULL
other	NULL
GATA-1	NULL
binding	NULL
sites	NULL
might	NULL
be	NULL
found	NULL
in	NULL
the	NULL
hEpoR	NULL
gene	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
other	NULL
GATA-1	NULL
binding	NULL
sites	NULL
outside	NULL
the	NULL
proximal	NULL
promoter	NULL
can	NULL
further	NULL
contribute	NULL
to	NULL
the	NULL
tissue-specific	NULL
expression	NULL
of	NULL
hEpoR	NULL
(	NULL
25	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
for	NULL
the	NULL
murine	NULL
EpoR	NULL
it	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
a	NULL
GATA-1	NULL
site	NULL
within	NULL
IVS1	NULL
of	NULL
murine	NULL
EpoR	NULL
provides	NULL
additional	NULL
positive	NULL
regulatory	NULL
activity	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Increasing	NULL
GATA-1	NULL
levels	NULL
results	NULL
in	NULL
transactivation	NULL
of	NULL
hEpoR	NULL
promoter	NULL
activity	NULL
in	NULL
erythroid	NULL
K562	NULL
and	NULL
non-erythroid	NULL
HeLa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

GATA-1	NULL
,	NULL
associated	NULL
predominantly	NULL
with	NULL
transcription	NULL
activation	NULL
of	NULL
erythroid-specific	NULL
genes	NULL
,	NULL
is	NULL
found	NULL
in	NULL
other	NULL
cell	NULL
lineages	NULL
,	NULL
such	NULL
as	NULL
megakaryocytes	NULL
and	NULL
mast	NULL
cells	NULL
(	NULL
17	NULL
)	NULL
.	NULL

EpoR	NULL
transcripts	NULL
have	NULL
also	NULL
been	NULL
observed	NULL
in	NULL
non-erythroid	NULL
hematopoietic	NULL
cells	NULL
expressing	NULL
GATA-1	NULL
(	NULL
27,28	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
importance	NULL
of	NULL
GATA-1	NULL
in	NULL
activation	NULL
of	NULL
the	NULL
endogenous	NULL
EpoR	NULL
gene	NULL
.	NULL

The	NULL
low	NULL
level	NULL
of	NULL
hEpoR	NULL
promoter	NULL
activity	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
which	NULL
do	NULL
not	NULL
express	NULL
GATA-1	NULL
,	NULL
is	NULL
similar	NULL
to	NULL
the	NULL
inactivity	NULL
of	NULL
the	NULL
murine	NULL
EpoR	NULL
promoter	NULL
in	NULL
mouse	NULL
fibroblasts	NULL
and	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Although	NULL
previous	NULL
reports	NULL
have	NULL
shown	NULL
that	NULL
GATA-1	NULL
is	NULL
able	NULL
to	NULL
transactivate	NULL
the	NULL
murine	NULL
EpoR	NULL
promoter	NULL
in	NULL
erythroid	NULL
(	NULL
29	NULL
)	NULL
and	NULL
non-erythroid	NULL
cells	NULL
(	NULL
30	NULL
)	NULL
,	NULL
we	NULL
found	NULL
that	NULL
increasing	NULL
the	NULL
level	NULL
of	NULL
3048	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1995	NULL
,	NULL
Vol	NULL
.	NULL

23	NULL
,	NULL
No	NULL
.	NULL

15	NULL
GATA-1	NULL
alone	NULL
was	NULL
not	NULL
sufficient	NULL
to	NULL
further	NULL
increase	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
hEpoR	NULL
promoter	NULL
in	NULL
erythroid	NULL
OCIM	NULL
1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
transactivation	NULL
of	NULL
hEpoR	NULL
by	NULL
GATA-1	NULL
may	NULL
be	NULL
saturable	NULL
,	NULL
as	NULL
observed	NULL
with	NULL
K562	NULL
and	NULL
HeLa	NULL
cells	NULL
at	NULL
high	NULL
levels	NULL
of	NULL
co-transfected	NULL
RSV-GATA-1	NULL
.	NULL

However	NULL
,	NULL
the	NULL
high	NULL
level	NULL
of	NULL
hEpoR	NULL
activity	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
depend	NULL
on	NULL
the	NULL
level	NULL
of	NULL
GATA-1	NULL
alone	NULL
,	NULL
as	NULL
Northern	NULL
blot	NULL
analysis	NULL
indicates	NULL
that	NULL
GATA-1	NULL
mRNA	NULL
in	NULL
OCIM1	NULL
and	NULL
K562	NULL
cells	NULL
are	NULL
comparable	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
phosphorylation	NULL
studies	NULL
of	NULL
GATA-1	NULL
suggest	NULL
that	NULL
DNA	NULL
binding	NULL
and	NULL
transcription	NULL
activity	NULL
are	NULL
not	NULL
affected	NULL
by	NULL
variation	NULL
in	NULL
phosphorylation	NULL
of	NULL
GATA-1	NULL
protein	NULL
(	NULL
31	NULL
)	NULL
.	NULL

However	NULL
,	NULL
other	NULL
differences	NULL
in	NULL
translational	NULL
or	NULL
post-translational	NULL
processing	NULL
or	NULL
differences	NULL
in	NULL
conformation	NULL
or	NULL
structure	NULL
of	NULL
GATA-1	NULL
protein	NULL
which	NULL
affect	NULL
the	NULL
activity	NULL
of	NULL
GATA-1	NULL
protein	NULL
are	NULL
possible	NULL
.	NULL

The	NULL
saturation	NULL
of	NULL
GATA-1	NULL
transactivation	NULL
in	NULL
OCIM1	NULL
cells	NULL
appears	NULL
to	NULL
be	NULL
specific	NULL
for	NULL
hEpoR	NULL
,	NULL
as	NULL
increasing	NULL
GATA-1	NULL
levels	NULL
were	NULL
able	NULL
to	NULL
transactivate	NULL
a	NULL
Ay-globin	NULL
promoter	NULL
construct	NULL
in	NULL
co-transfection	NULL
assays	NULL
using	NULL
OCIM1	NULL
cells	NULL
.	NULL

The	NULL
high	NULL
and	NULL
low	NULL
levels	NULL
of	NULL
hEpoR	NULL
activity	NULL
in	NULL
erythroid	NULL
cells	NULL
are	NULL
particularly	NULL
relevant	NULL
to	NULL
differential	NULL
expression	NULL
of	NULL
the	NULL
hEpoR	NULL
gene	NULL
during	NULL
erythropoiesis	NULL
.	NULL

For	NULL
human	NULL
primary	NULL
erythroid	NULL
cells	NULL
BFU-E	NULL
(	NULL
burst	NULL
forming	NULL
units-erythroid	NULL
)	NULL
exhibit	NULL
<	NULL
200	NULL
hEpoR/cell	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Stimulation	NULL
by	NULL
Epo	NULL
results	NULL
in	NULL
differentiation	NULL
and	NULL
maturation	NULL
to	NULL
CFU-E	NULL
(	NULL
colony	NULL
forming	NULL
unit-erythroid	NULL
)	NULL
which	NULL
contain	NULL
1100	NULL
hEpoR/cell	NULL
as	NULL
the	NULL
erythroid	NULL
precursors	NULL
become	NULL
Epo-dependent	NULL
.	NULL

With	NULL
increasing	NULL
maturation	NULL
the	NULL
number	NULL
of	NULL
receptors	NULL
decreases	NULL
and	NULL
none	NULL
are	NULL
detected	NULL
on	NULL
human	NULL
reticulocytes	NULL
.	NULL

Epo	NULL
stimulation	NULL
of	NULL
erythroid	NULL
progenitors	NULL
and	NULL
subsequent	NULL
proliferation	NULL
and	NULL
differentiation	NULL
is	NULL
accompanied	NULL
by	NULL
an	NULL
increase	NULL
in	NULL
GATA-1	NULL
levels	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Transactivation	NULL
of	NULL
the	NULL
EpoR	NULL
promoter	NULL
by	NULL
GATA-1	NULL
and	NULL
the	NULL
association	NULL
between	NULL
increased	NULL
EpoR	NULL
expression	NULL
and	NULL
increased	NULL
GATA-1	NULL
levels	NULL
in	NULL
primary	NULL
erythroid	NULL
cultures	NULL
suggest	NULL
that	NULL
GATA-1	NULL
contributes	NULL
significantly	NULL
to	NULL
activation	NULL
of	NULL
the	NULL
EpoR	NULL
gene	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
here	NULL
also	NULL
indicate	NULL
that	NULL
expression	NULL
of	NULL
GATA-1	NULL
alone	NULL
is	NULL
insufficient	NULL
to	NULL
determine	NULL
the	NULL
level	NULL
of	NULL
activity	NULL
of	NULL
the	NULL
EpoR	NULL
gene	NULL
.	NULL

Adjacent	NULL
to	NULL
the	NULL
GATA-1	NULL
binding	NULL
motif	NULL
at	NULL
-45	NULL
bp	NULL
is	NULL
the	NULL
Spl	NULL
binding	NULL
motif	NULL
at	NULL
-17	NULL
bp	NULL
,	NULL
but	NULL
no	NULL
TATA	NULL
sequence	NULL
.	NULL

As	NULL
with	NULL
many	NULL
TATA-less	NULL
promoters	NULL
,	NULL
hEpoR	NULL
contains	NULL
an	NULL
initiator	NULL
sequence	NULL
with	NULL
the	NULL
Sp1	NULL
binding	NULL
site	NULL
in	NULL
proximity	NULL
,	NULL
which	NULL
maps	NULL
to	NULL
a	NULL
stretch	NULL
of	NULL
27	NULL
nt	NULL
with	NULL
89	NULL
%	NULL
homology	NULL
to	NULL
the	NULL
murine	NULL
EpoR	NULL
gene	NULL
(	NULL
3	NULL
)	NULL
and	NULL
overlaps	NULL
with	NULL
a	NULL
17	NULL
bp	NULL
motif	NULL
with	NULL
76	NULL
%	NULL
homology	NULL
to	NULL
the	NULL
initiator	NULL
sequence	NULL
region	NULL
for	NULL
the	NULL
IL-3B	NULL
receptor	NULL
gene	NULL
(	NULL
34	NULL
)	NULL
.	NULL

For	NULL
transcription	NULL
initiation	NULL
TBP	NULL
(	NULL
TATA	NULL
binding	NULL
protein	NULL
)	NULL
is	NULL
still	NULL
required	NULL
as	NULL
part	NULL
of	NULL
the	NULL
transcription	NULL
complex	NULL
and	NULL
Spl	NULL
in	NULL
conjunction	NULL
with	NULL
other	NULL
co-activators	NULL
and	NULL
a	NULL
multisubunit	NULL
TFIID	NULL
complex	NULL
are	NULL
able	NULL
to	NULL
direct	NULL
transcription	NULL
(	NULL
35	NULL
)	NULL
.	NULL

However	NULL
,	NULL
for	NULL
the	NULL
hEpoR	NULL
promoter	NULL
we	NULL
observed	NULL
no	NULL
direct	NULL
interactions	NULL
between	NULL
the	NULL
promoter	NULL
and	NULL
TFIID	NULL
in	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
using	NULL
TFIID-specific	NULL
antibodies	NULL
and	NULL
a	NULL
TFIID-specific	NULL
DNA	NULL
competitor	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

Using	NULL
antibodies	NULL
specific	NULL
for	NULL
Spi	NULL
and	NULL
Spl	NULL
-specific	NULL
DNA	NULL
competitors	NULL
we	NULL
observed	NULL
explicit	NULL
binding	NULL
of	NULL
Spl	NULL
and	NULL
two	NULL
non-Sp1	NULL
proteins	NULL
to	NULL
the	NULL
hEpoR	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Spl	NULL
was	NULL
a	NULL
critical	NULL
element	NULL
in	NULL
transcription	NULL
activation	NULL
of	NULL
the	NULL
hEpoR	NULL
promoter	NULL
,	NULL
as	NULL
mutation	NULL
of	NULL
the	NULL
Spl	NULL
binding	NULL
motif	NULL
(	NULL
ASp1	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
marked	NULL
decrease	NULL
in	NULL
hEpoR	NULL
transcription	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

However	NULL
,	NULL
differential	NULL
activation	NULL
of	NULL
the	NULL
hEpoR	NULL
promoter	NULL
in	NULL
erythroid	NULL
K562	NULL
and	NULL
OCIM	NULL
1	NULL
cells	NULL
was	NULL
not	NULL
due	NULL
to	NULL
limiting	NULL
amounts	NULL
of	NULL
Spl	NULL
,	NULL
as	NULL
co-transfection	NULL
with	NULL
the	NULL
hEpoR	NULL
promoter	NULL
and	NULL
an	NULL
Spl	NULL
expression	NULL
vector	NULL
did	NULL
not	NULL
affect	NULL
hEpoR	NULL
promoter	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Little	NULL
or	NULL
no	NULL
high	NULL
molecular	NULL
weight	NULL
material	NULL
corresponding	NULL
to	NULL
simultaneous	NULL
binding	NULL
of	NULL
GATA-1	NULL
and	NULL
Spl	NULL
was	NULL
detected	NULL
.	NULL

Interestingly	NULL
,	NULL
in	NULL
gel	NULL
shift	NULL
assays	NULL
with	NULL
probe	NULL
containing	NULL
the	NULL
Spl	NULL
and	NULL
GATA-1	NULL
binding	NULL
motifs	NULL
competition	NULL
for	NULL
nuclear	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
GATA-1	NULL
motif	NULL
using	NULL
GATA-1	NULL
DNA	NULL
competitors	NULL
or	NULL
anti-GATA-1	NULL
antibody	NULL
resulted	NULL
in	NULL
apparent	NULL
increased	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
Spl	NULL
motif	NULL
(	NULL
and	NULL
vice	NULL
versa	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
)	NULL
,	NULL
suggesting	NULL
a	NULL
relationship	NULL
(	NULL
possibly	NULL
interference	NULL
)	NULL
between	NULL
binding	NULL
to	NULL
these	NULL
two	NULL
motifs	NULL
,	NULL
likely	NULL
due	NULL
to	NULL
their	NULL
close	NULL
proximity	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
increasing	NULL
the	NULL
spacing	NULL
between	NULL
these	NULL
motifs	NULL
changes	NULL
promoter	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

When	NULL
the	NULL
GATA-1	NULL
expression	NULL
vector	NULL
was	NULL
co-transfected	NULL
with	NULL
the	NULL
ASpl	NULL
plasmid	NULL
with	NULL
low	NULL
activity	NULL
into	NULL
OCIM1	NULL
cells	NULL
we	NULL
observed	NULL
transactivation	NULL
by	NULL
increased	NULL
GATA-1	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
both	NULL
Spl	NULL
and	NULL
GATA-1	NULL
are	NULL
critical	NULL
elements	NULL
in	NULL
determining	NULL
transcription	NULL
activation	NULL
of	NULL
the	NULL
hEpoR	NULL
promoter	NULL
and	NULL
that	NULL
coordination	NULL
of	NULL
Spl	NULL
and	NULL
GATA-1	NULL
with	NULL
other	NULL
cell-specific	NULL
elements	NULL
,	NULL
possibly	NULL
including	NULL
other	NULL
Spli-like	NULL
nuclear	NULL
proteins	NULL
,	NULL
determines	NULL
the	NULL
high	NULL
level	NULL
of	NULL
hEpoR	NULL
transcription	NULL
activation	NULL
.	NULL

Interaction	NULL
between	NULL
transcription	NULL
factors	NULL
Spl	NULL
and	NULL
GATA-1	NULL
has	NULL
been	NULL
hypothesized	NULL
as	NULL
a	NULL
possible	NULL
mechanism	NULL
for	NULL
stage-specific	NULL
expression	NULL
of	NULL
globin	NULL
genes	NULL
(	NULL
36	NULL
)	NULL
and	NULL
for	NULL
erythroid-specific	NULL
expression	NULL
of	NULL
non-globin	NULL
genes	NULL
(	NULL
21	NULL
)	NULL
.	NULL

In	NULL
addi-tion	NULL
,	NULL
the	NULL
sensitivity	NULL
to	NULL
the	NULL
hEpoR	NULL
promoter	NULL
to	NULL
alteration	NULL
of	NULL
the	NULL
GATA-1	NULL
binding	NULL
sequence	NULL
suggests	NULL
that	NULL
expression	NULL
of	NULL
EpoR	NULL
in	NULL
non-erythroid	NULL
tissues	NULL
,	NULL
such	NULL
as	NULL
endothelial	NULL
cells	NULL
(	NULL
10	NULL
)	NULL
and	NULL
brain	NULL
(	NULL
6,37,38	NULL
)	NULL
,	NULL
may	NULL
represent	NULL
coordinate	NULL
expression	NULL
of	NULL
Spl	NULL
with	NULL
other	NULL
GATA-like	NULL
proteins	NULL
(	NULL
19,20	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
in	NULL
non-erythroid	NULL
cells	NULL
GATA-2	NULL
may	NULL
interact	NULL
with	NULL
this	NULL
motif	NULL
and	NULL
may	NULL
confer	NULL
little	NULL
,	NULL
or	NULL
even	NULL
negative	NULL
,	NULL
transcription	NULL
control	NULL
.	NULL

The	NULL
relative	NULL
activities	NULL
of	NULL
the	NULL
hEpoR	NULL
reporter	NULL
gene	NULL
constructs	NULL
in	NULL
erythroid	NULL
OCIM1	NULL
and	NULL
K562	NULL
cells	NULL
reflected	NULL
the	NULL
high	NULL
and	NULL
low	NULL
levels	NULL
of	NULL
endogenous	NULL
gene	NULL
expression	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
soluble	NULL
factors	NULL
may	NULL
be	NULL
sufficient	NULL
to	NULL
account	NULL
for	NULL
the	NULL
differences	NULL
in	NULL
hEpoR	NULL
gene	NULL
expression	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
although	NULL
the	NULL
A1778	NULL
hEpoR	NULL
construct	NULL
was	NULL
active	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
the	NULL
endogenous	NULL
hEpoR	NULL
gene	NULL
is	NULL
silent	NULL
.	NULL

Furthermore	NULL
,	NULL
an	NULL
hEpoR	NULL
transgene	NULL
containing	NULL
this	NULL
5	NULL
flanking	NULL
region	NULL
exhibits	NULL
appropriate	NULL
tissue-specific	NULL
expression	NULL
in	NULL
transgenic	NULL
mice	NULL
(	NULL
6	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
erythroid-specific	NULL
expression	NULL
of	NULL
hEpoR	NULL
may	NULL
be	NULL
dependent	NULL
on	NULL
other	NULL
factors	NULL
not	NULL
present	NULL
in	NULL
transient	NULL
transfections	NULL
,	NULL
such	NULL
as	NULL
DNA	NULL
structure	NULL
(	NULL
chromatin	NULL
)	NULL
or	NULL
DNA	NULL
modification	NULL
(	NULL
meth-lyation	NULL
)	NULL
,	NULL
to	NULL
provide	NULL
negative	NULL
regulation	NULL
or	NULL
suppression	NULL
of	NULL
hEpoR	NULL
expression	NULL
in	NULL
non-erythroid	NULL
cells	NULL
or	NULL
may	NULL
require	NULL
additional	NULL
regulatory	NULL
sequences	NULL
3	NULL
'	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
which	NULL
are	NULL
included	NULL
in	NULL
the	NULL
hEpoR	NULL
transgene	NULL
.	NULL

Although	NULL
the	NULL
Spl	NULL
and	NULL
GATA-1	NULL
binding	NULL
motifs	NULL
are	NULL
necessary	NULL
elements	NULL
for	NULL
hEpoR	NULL
promoter	NULL
activity	NULL
,	NULL
they	NULL
are	NULL
not	NULL
sufficient	NULL
to	NULL
provide	NULL
erythroid-specific	NULL
hEpoR	NULL
expression	NULL
.	NULL

ACKNOWLEDGEMENTS	NULL
We	NULL
thank	NULL
Drs	NULL
A.	NULL
Schechter	NULL
,	NULL
H.	NULL
Chin	NULL
and	NULL
Z.	NULL
Liu	NULL
for	NULL
helpful	NULL
discussions	NULL
,	NULL
Drs	NULL
G.	NULL
Felsenfeld	NULL
and	NULL
C.	NULL
Trainer	NULL
for	NULL
the	NULL
RSVGATA-1	NULL
expression	NULL
plasmid	NULL
,	NULL
Dr	NULL
S.	NULL
Ikuyama	NULL
for	NULL
plasmid	NULL
pSVGH	NULL
,	NULL
and	NULL
Dr	NULL
S.	NULL
Jane	NULL
for	NULL
the	NULL
Ay-globin	NULL
promoter-luciferase	NULL
reporter	NULL
gene	NULL
construct	NULL
.	NULL

REFERENCES	NULL
1	NULL
-	NULL
Youssoufian	NULL
,	NULL
H.	NULL
,	NULL
Longmore	NULL
,	NULL
G.	NULL
,	NULL
Neumann	NULL
,	NULL
D.	NULL
,	NULL
Yoshimura	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Lodish	NULL
,	NULL
H.F	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Blood	NULL
,	NULL
81	NULL
,	NULL
2223-2236	NULL
.	NULL

2	NULL
Witthuhn	NULL
,	NULL
B.A	NULL
.	NULL

,	NULL
Quelle	NULL
,	NULL
EW	NULL
.	NULL

,	NULL
Silvennoinen,0	NULL
.	NULL

,	NULL
Yi	NULL
,	NULL
T.	NULL
,	NULL
Tang	NULL
,	NULL
B.	NULL
,	NULL
Miura	NULL
,	NULL
O	NULL
.	NULL

and	NULL
Thie	NULL
,	NULL
J.N	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Cell	NULL
,	NULL
74	NULL
,	NULL
227-236	NULL
.	NULL

3	NULL
Noguchi	NULL
,	NULL
C.T	NULL
.	NULL

,	NULL
Bae	NULL
,	NULL
K.S	NULL
.	NULL

,	NULL
Chin	NULL
,	NULL
K.	NULL
,	NULL
Wada	NULL
,	NULL
Y.	NULL
,	NULL
Schechter	NULL
,	NULL
A.N	NULL
.	NULL

and	NULL
Hankins	NULL
,	NULL
W.D	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Blood	NULL
,	NULL
78	NULL
,	NULL
2548-2556	NULL
.	NULL

Maouche	NULL
,	NULL
L.	NULL
,	NULL
Tournamille	NULL
,	NULL
C.	NULL
,	NULL
Hattab	NULL
,	NULL
C.	NULL
,	NULL
Boffa	NULL
,	NULL
G	NULL
.	NULL

and	NULL
Cartron	NULL
,	NULL
J.P.	NULL
,	NULL
Chretien	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Blood	NULL
,	NULL
78	NULL
,	NULL
2557-2563	NULL
.	NULL

Penny	NULL
,	NULL
L.A	NULL
.	NULL

and	NULL
Forget	NULL
,	NULL
B.G	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Genomics	NULL
,	NULL
11	NULL
,	NULL
974-980	NULL
.	NULL

Liu	NULL
,	NULL
Z.	NULL
,	NULL
Chin	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Noguchi	NULL
,	NULL
C.T	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Dev	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
166	NULL
,	NULL
159-169	NULL
.	NULL

Broudy	NULL
,	NULL
V.C	NULL
.	NULL

,	NULL
Lin	NULL
,	NULL
N.	NULL
,	NULL
Egrie	NULL
,	NULL
J.	NULL
,	NULL
de	NULL
Haen	NULL
,	NULL
C.	NULL
,	NULL
Weiss	NULL
,	NULL
T.	NULL
,	NULL
Papayannopoulou	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Adamson	NULL
,	NULL
J.W	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
85	NULL
,	NULL
6513-6517	NULL
.	NULL

Fraser	NULL
,	NULL
J.K.	NULL
,	NULL
Lin	NULL
,	NULL
EK	NULL
.	NULL

and	NULL
Berridge.M.V	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Blood	NULL
,	NULL
71	NULL
,	NULL
104-109	NULL
.	NULL

Jeannesson	NULL
,	NULL
P.	NULL
,	NULL
Trentesaux	NULL
,	NULL
C.	NULL
,	NULL
Nyong.M.N	NULL
.	NULL

,	NULL
Mayeux	NULL
,	NULL
P.	NULL
,	NULL
Jacquot	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Jardillier.J.C	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Leukemia	NULL
,	NULL
5	NULL
,	NULL
14-18	NULL
.	NULL

Anagnostou	NULL
,	NULL
A.	NULL
,	NULL
Liu	NULL
,	NULL
Z.	NULL
,	NULL
Steiner	NULL
,	NULL
M.	NULL
,	NULL
Chin	NULL
,	NULL
K.	NULL
,	NULL
Lee	NULL
,	NULL
E.S	NULL
.	NULL

,	NULL
Kessimian	NULL
,	NULL
N	NULL
.	NULL

and	NULL
Noguchi	NULL
,	NULL
C.T	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
91	NULL
,	NULL
3974-3978	NULL
.	NULL

Papayannopoulou,7T	NULL
.	NULL

,	NULL
Nakamoto	NULL
,	NULL
B.	NULL
,	NULL
Kurachi	NULL
,	NULL
S.	NULL
,	NULL
Tweeddale	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Messner	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Blood	NULL
,	NULL
72	NULL
,	NULL
1029-1038	NULL
.	NULL

Lozzio	NULL
,	NULL
C.B	NULL
.	NULL

and	NULL
Lozzi0	NULL
,	NULL
B.B	NULL
.	NULL

(	NULL
1975	NULL
)	NULL
Blood	NULL
,	NULL
45	NULL
,	NULL
321-334	NULL
.	NULL

Peters	NULL
,	NULL
B.	NULL
,	NULL
Merezhinskaya	NULL
,	NULL
N.	NULL
,	NULL
Diffley	NULL
,	NULL
J.F	NULL
.	NULL

and	NULL
Noguchi	NULL
,	NULL
C.T	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
268	NULL
,	NULL
3430-3437	NULL
.	NULL

Ryder	NULL
,	NULL
K.	NULL
,	NULL
Lau	NULL
,	NULL
L.F	NULL
.	NULL

and	NULL
Nathans	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
85	NULL
,	NULL
1487-1491	NULL
.	NULL

Dignam	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
Lebovitz	NULL
,	NULL
R.M	NULL
.	NULL

and	NULL
Roeder	NULL
,	NULL
R.G	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
11	NULL
,	NULL
1475-1489	NULL
.	NULL

Briggs	NULL
,	NULL
M.R	NULL
.	NULL

,	NULL
Kadonaga	NULL
,	NULL
J.T	NULL
.	NULL

,	NULL
Bell	NULL
,	NULL
S.P	NULL
.	NULL

and	NULL
Tjian	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Science	NULL
,	NULL
234	NULL
,	NULL
47-52	NULL
.	NULL

Orkin	NULL
,	NULL
S.H	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Blood	NULL
,	NULL
80	NULL
,	NULL
575-581	NULL
.	NULL

Ito	NULL
,	NULL
E.	NULL
,	NULL
Toki	NULL
,	NULL
T.	NULL
,	NULL
Ishihara	NULL
,	NULL
H.	NULL
,	NULL
Ohtani	NULL
,	NULL
H.	NULL
,	NULL
Gu	NULL
,	NULL
L.	NULL
,	NULL
Yokoyama	NULL
,	NULL
M.	NULL
,	NULL
Engel	NULL
,	NULL
J.D	NULL
.	NULL

and	NULL
Yamamoto	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Nature	NULL
,	NULL
362	NULL
,	NULL
466-468	NULL
.	NULL

Ko	NULL
,	NULL
L.J	NULL
.	NULL

and	NULL
Engel	NULL
,	NULL
J.D	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
13	NULL
,	NULL
4011-4022	NULL
.	NULL

Merika	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Orkin	NULL
,	NULL
S.H	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
13	NULL
,	NULL
3999-4010	NULL
.	NULL

Raich	NULL
,	NULL
N	NULL
.	NULL

and	NULL
Romeo	NULL
,	NULL
PH	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Stem	NULL
Cells	NULL
,	NULL
11	NULL
,	NULL
95-104	NULL
.	NULL

Youssoufian	NULL
,	NULL
H.	NULL
,	NULL
Zon	NULL
,	NULL
L.L	NULL
,	NULL
Orkin	NULL
,	NULL
S.H	NULL
.	NULL

,	NULL
D'Andrea	NULL
,	NULL
A.D.	NULL
and	NULL
Lodish	NULL
,	NULL
H.F	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
10	NULL
,	NULL
3675-3682	NULL
.	NULL

23	NULL
25	NULL
26	NULL
27	NULL
28	NULL
29	NULL
30	NULL
31	NULL
32	NULL
33	NULL
34	NULL
35	NULL
37	NULL
38	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1995	NULL
,	NULL
Vol	NULL
.	NULL

23	NULL
,	NULL
No	NULL
.	NULL

15	NULL
3049	NULL
Youssoufian	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Blood	NULL
,	NULL
83	NULL
,	NULL
1428-1435	NULL
.	NULL

Youssoufian	NULL
,	NULL
H	NULL
.	NULL

and	NULL
Lodish	NULL
,	NULL
H.F	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
13	NULL
,	NULL
98-104	NULL
.	NULL

Maouche.L	NULL
.	NULL

,	NULL
Cartron	NULL
,	NULL
J.P	NULL
.	NULL

and	NULL
Chretien	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
22	NULL
,	NULL
338-346	NULL
.	NULL

Heberlein.C	NULL
.	NULL

,	NULL
Fischer.K.D	NULL
.	NULL

,	NULL
Stoffel	NULL
,	NULL
M.	NULL
,	NULL
Nowock	NULL
,	NULL
J.	NULL
,	NULL
Ford	NULL
,	NULL
A.	NULL
,	NULL
Tessmer	NULL
,	NULL
U	NULL
.	NULL

and	NULL
Stocking	NULL
,	NULL
C	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
12	NULL
,	NULL
1815-1826	NULL
.	NULL

Komatsu	NULL
,	NULL
N	NULL
.	NULL

and	NULL
Fujita	NULL
,	NULL
H	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

,	NULL
53	NULL
,	NULL
1156-1161	NULL
.	NULL

Migliaccio	NULL
,	NULL
A.R	NULL
.	NULL

,	NULL
Jiang	NULL
,	NULL
Y.	NULL
,	NULL
Migliaccio	NULL
,	NULL
G.	NULL
,	NULL
Nicolis	NULL
,	NULL
S.	NULL
,	NULL
Crotta	NULL
,	NULL
S.	NULL
,	NULL
Ronchi	NULL
,	NULL
A.	NULL
,	NULL
Ottolenghi	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Adamson	NULL
,	NULL
J.W	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Blood	NULL
,	NULL
82	NULL
,	NULL
3760-3769	NULL
.	NULL

Chiba	NULL
,	NULL
T.	NULL
,	NULL
Ikawa	NULL
,	NULL
Y	NULL
.	NULL

and	NULL
Todokoro	NULL
,	NULL
K	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
19	NULL
,	NULL
3843-3848	NULL
.	NULL

Zon	NULL
,	NULL
L.L	NULL
.	NULL

,	NULL
Youssoufian	NULL
,	NULL
H.	NULL
,	NULL
Mather	NULL
,	NULL
C.	NULL
,	NULL
Lodish	NULL
,	NULL
H.F	NULL
.	NULL

and	NULL
Orkin	NULL
,	NULL
S.H	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
88	NULL
,	NULL
10638-10641	NULL
.	NULL

Crossley	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Orkin	NULL
,	NULL
S.H	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
269	NULL
,	NULL
16589-16596	NULL
.	NULL

Broudy	NULL
,	NULL
V.C	NULL
.	NULL

,	NULL
Lin	NULL
,	NULL
N.	NULL
,	NULL
Brice	NULL
,	NULL
M.	NULL
,	NULL
Nakamoto	NULL
,	NULL
B	NULL
.	NULL

and	NULL
Papayannopoulou	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Blood	NULL
,	NULL
77	NULL
,	NULL
2583-2590	NULL
.	NULL

Daylot	NULL
,	NULL
N.	NULL
,	NULL
Fibach	NULL
,	NULL
E.	NULL
,	NULL
Ronchi	NULL
,	NULL
A.	NULL
,	NULL
Rachmilewitz	NULL
,	NULL
E	NULL
.	NULL

A.	NULL
,	NULL
Ottolenghi	NULL
,	NULL
$	NULL
.	NULL

and	NULL
Oppenheim	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
,	NULL
21	NULL
,	NULL
4031-4037	NULL
.	NULL

Gorman	NULL
,	NULL
D.M	NULL
.	NULL

,	NULL
Itoh	NULL
,	NULL
N.	NULL
,	NULL
Jenkins	NULL
,	NULL
Gilbert	NULL
,	NULL
D.J	NULL
.	NULL

,	NULL
Copeland	NULL
,	NULL
N.G	NULL
.	NULL

and	NULL
Miyajima	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
267	NULL
,	NULL
15842-15848	NULL
.	NULL

Pugh	NULL
,	NULL
B.F	NULL
.	NULL

and	NULL
Tjian	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
5	NULL
,	NULL
1935-1945	NULL
.	NULL

Minie.M	NULL
.	NULL

,	NULL
Clark	NULL
,	NULL
D.	NULL
,	NULL
Trainor	NULL
,	NULL
C.	NULL
,	NULL
Evans	NULL
,	NULL
T.	NULL
,	NULL
Reitman	NULL
,	NULL
M.	NULL
,	NULL
Hannon	NULL
,	NULL
R.	NULL
,	NULL
Gould.H	NULL
.	NULL

and	NULL
Felsenfeld	NULL
,	NULL
G	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Sci	NULL
.	NULL

,	NULL
16	NULL
(	NULL
suppl	NULL
.	NULL
)	NULL

,	NULL
15-20	NULL
.	NULL

Masuda	NULL
,	NULL
$	NULL
.	NULL

,	NULL
Nagao	NULL
,	NULL
M.	NULL
,	NULL
Takahata	NULL
,	NULL
K.	NULL
,	NULL
Konishi	NULL
,	NULL
Y.	NULL
,	NULL
Gallyas	NULL
,	NULL
FJ	NULL
.	NULL

,	NULL
Tabira	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Sasaki	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
268	NULL
,	NULL
11208-11216	NULL
.	NULL

Digicaylioglu	NULL
,	NULL
M.	NULL
,	NULL
Bichet	NULL
,	NULL
S.	NULL
,	NULL
Marti	NULL
,	NULL
H.H	NULL
.	NULL

,	NULL
Wenger	NULL
,	NULL
R.H.	NULL
,	NULL
Rivas	NULL
,	NULL
L.A.	NULL
,	NULL
Bauer	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Gassmann	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
92	NULL
,	NULL
3717-3720	NULL
.	NULL

